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ABSTRACT
Despite the growing evidence that circulating sex hormones during puberty may help
explain the subtle sex differences that exist in the symptom profile, neuropathology
and clinical sequelae of ADHD, there is limited research in this area. The current
study investigated how the timing of female pubertal maturation influences the extent
of ADHD symptoms in a non-clinical female undergraduate sample (N=253).
Participants completed a set of self-report rating scales examining pubertal onset, and
ADHD symptoms and related deficits. Using logistic regression models, difficulties in
attention, emotion regulation, psychosocial functioning and more risky behaviour
were shown to significantly help classify those who reported having an earlier
pubertal onset relative to their peers. That is, early puberty was associated with
increased symptom endorsement on a variety of ADHD-related variables. Findings
highlight the potential role of sex hormones during puberty in explaining the
differences in gender prevalence rates of ADHD and symptom profiles.
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CHAPTER I
Introduction
Attention deficit/hyperactivity disorder (ADHD) is a neurobehavioural
developmental disorder typically diagnosed in childhood (APA, 2013; Miller, 2012).
Although prevalence rates vary widely due to methodological issues (e.g., sampling
techniques, diagnostic criteria), ADHD continues to be the most common childhood
psychiatric diagnosis affecting approximately 5.5% of children worldwide (Polanczyk, de
Lima, Horta, Biederman, & Rohde, 2007). Over the last couple of decades, there has
been increasing awareness that the symptoms observed in childhood often continue into
adulthood, with many children with ADHD not “outgrowing” the disorder (Barkley,
Fischer, Edelbrock, & Smallish, 1990; Kalbag & Levin, 2005; Halperin, Trampush,
Miller, Marks, & Newcorn, 2008), although there is debate over the extent of symptom
preservation (Hill & Schoener, 1996; Mannuzza et al., 1991). Nevertheless, data on
prevalence rates in adolescence and adulthood are limited and likely echo both underdiagnosis and lack of clinical attention given to this age range (Kalbag & Levin, 2005;
Miller, 2012). According to Fayyad and colleagues (2007), ADHD affects approximately
3-4% of the adult population worldwide. Such a remarkable statistic supports the fact that
adult ADHD requires more attention and needs to be studied more thoroughly.
To receive an adult diagnosis of ADHD, several symptoms present before age 12
must persist into adulthood (APA, 2013a). However, late adolescents and young adults
with ADHD and their parents have limited recall of childhood ADHD symptoms,
questioning the validity and use of such retrospective data when making a diagnosis
(Barkley, Knouse, & Murphy, 2011; Miller, Newcorn, & Halperin, 2010). Relatedly,
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there is a tendency for adults to not connect ADHD symptoms and associated
impairments to adult ADHD if they were not diagnosed as children (Kalbag & Levin,
2005), and rather to attribute them to personality or character traits (Barkley & Brown,
2008). Finally, while it has been suggested that the symptoms required by the Diagnostic
and Statistical Manual of Mental Disorders (DSM) may not be developmentally
appropriate, the current DSM has not made changes to the diagnostic criteria to
appropriately address the changes in developmental norms across the life span (APA,
2013b; Barkley, Murphy, & Fischer, 2008; Miller, 2010). Gaps in our current
understanding of adult ADHD, and poor consensus regarding what might constitute
appropriate diagnostic criteria highlight the need for research investigating the
persistence of this disorder into adulthood, with the goal of developing new criteria that
incorporates symptoms more relevant to the challenges encountered by young adults.
Across clinical settings ADHD is reported to be more common in males than in
females, with male childhood rates approximately two times larger than females (APA,
2013a). Notably, studies examining ADHD symptoms, including those based on
university samples, overwhelmingly sample males (Biederman et al., 1993, as cited in
Rodriguez & Span, 2008). Consequently, the manifestation of ADHD in females has
been neglected in the literature, as have sex differences in ADHD (Arnold, 1996). It has
been speculated that this paucity in the literature, in addition to sex differences in the
outward display of ADHD symptoms, has led to the sex discrepancy in clinical referrals
and sampling bias (Mahone, 2010; Sciutto, Nolfi, & Bluhm, 2004). For instance, even
when the expression of ADHD symptoms is equal, teachers are still more likely to refer
boys than girls for treatment (Sciutto et al., 2004). Whereas childhood prevalence rates
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continuously suggest greater ADHD rates for males than females, there is some
indication that the male bias in ADHD is eliminated by adulthood (DuPaul et al., 2001;
Nussbaum, 2012). Importantly, females with ADHD are equally susceptible to life
course impairments as are males (Lee, Lahey, Owens, & Hinshaw, 2008), and may even
be more prone to particular disorders (e.g., eating disorders; Biederman et al., 2010).
Thus, this neglect is a public health concern affecting hundreds of thousands of affected
females (Arnold, 1996).
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CHAPTER II
Review of Literature
Organization of Review
This chapter begins with a review of the relevant literature on attention deficit
hyperactivity disorder (ADHD), followed by a discussion on human pubertal
development. This is then followed by the presentation of literature supporting a link
between female pubertal development and sex-specific ADHD symptom manifestation.
Finally, an outline of the purpose of the proposed study and the research questions is
given.
Attention Deficit Hyperactivity Disorder
The most current edition of the DSM (DSM-5) defines ADHD as a “persistent
pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or
development” (APA, 2013a, p. 59). The DSM-5, like the DSM-IV-TR, distinguishes four
subtypes of ADHD: Combined type, Predominantly Inattentive, Predominantly
Hyperactive-Impulsive, and Other Specified ADHD. The Combined type is the most
common, accounting for 50-75% of diagnoses, and requires at least a total of six
symptoms from both the hyperactive-impulsive and inattentive domains for diagnosis
(APA, 2013a; Miller, 2012). Notably, new to the DSM-5, the symptom threshold for
those aged 17 and older has been lowered from six to five symptoms (APA, 2013a).
Some symptoms indicative of an attention deficit are inability to ‘sustain attention’,
‘easily distracted’ and ‘often forgetful’ (APA, 2013a). Examples of symptoms falling
under the hyperactivity-impulsivity domain include, but are not limited to, ‘often fidgets’,
‘runs about or climbs excessively in situations where inappropriate’, ‘talks excessively’,
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and has ‘difficulty awaiting turn’ (APA, 2013a). Predominantly Inattentive and
Predominantly Hyperactive-Impulsive subtypes account for 20-30% and less than 15% of
diagnoses, respectively (Miller, 2012). The diagnosis of either subtype requires that the
six symptoms (or five for older adolescents and adults) cluster within either the
inattention or hyperactive-impulsive domains, although there may also be subclinical
features present that would fall under the other category (APA, 2013a). Finally, the last
subtype, Other Specified ADHD, is the subtype chosen when in the presence of
significant impairment and distress there are prominent symptoms present yet they do not
sufficiently meet all the criteria (APA, 2013a). Evident from the examples given above
and in line with the criticism of the current DSM diagnostic criteria described above, this
continues to be a very child-centric definition of ADHD. The DSM-5 committee
attempted to remedy this by providing clinicians with examples of the types of
behaviours that might manifest in older adolescents and adults with ADHD (APA,
2013b). The manifestation of symptoms in adults is different, and characterized more by
symptoms such as ‘racing thoughts’, ‘restlessness’, ‘making careless mistakes when work
on a boring or difficult project’, ‘problems remembering appointments’, ‘feeling overly
energetic and compelled to do things’, and ‘disrupting others when they are occupied’
(Barkley, 2011; Kessler, 2005). It is important to note that whereas the use of these
subtypes is common practice in North America, there is some indication that these
subtypes are developmentally unstable (Lahey, Pelham, Loney, Lee, & Willcutt, 2005;
Todd et al., 2008). Moreover, population-based behaviour genetic studies examining
preferential familial clustering in the study of complex genetic traits, such as ADHD,
suggest that ADHD is a single dimensional phenotype that varies in severity across
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humans, and that when two dimensions are found, they are highly correlated (Acosta,
Arcos-Burgos, & Muenke, 2004). Thus the utility of subtyping ADHD may be limited.
ADHD has been predominantly conceptualized as a disorder of executive
functioning, and thus commonly linked to a dysfunction of neural circuits in the
prefrontal cortex (PFC) and the catecholamine neurotransmitter systems (Barkley, 1997;
Halperin & Schulz, 2006; Nussbaum, 2012). In line with this conceptualization, children
and adults with ADHD have shown impairment on a number of neuropsychological
measures of executive function, including inhibitory control, self-regulation, planning,
working memory, and shifting sets (Halperin & Schulz, 2006; Nussbaum, 2012). To
explain the executive functioning deficit present in ADHD, Barkley (2011d)
conceptualizes the disorder as age-inappropriate behaviour in two domains of
neuropsychological functioning that parallel the DSM subtypes categorization:
Hyperactivity-Impulsivity (Inhibition) and Inattention (Meta-Cognition). Symptoms
within the domain of hyperactivity-impulsivity reflect poor inhibition and are
characterized by impairment in verbal and motor inhibition, impulsive decision making,
inability to delay gratification, greater disregard for future consequences, excessive taskirrelevant movement and emotional impulsiveness (Barkley, 1997; Barkley, 2011d;
Brown, 2006). Conversely, the ADHD deficit in attention is exemplified by impairment
in resistance to responding to distraction, low persistence toward goals or tasks, poor
working memory, difficulty re-engaging in a task following disruptions and poor
emotional self-regulation (Barkley, 1997; Barkley, 2011d; Brown, 2006). It is important
to note that this conceptualization of ADHD has not been unequivocally supported.
Halperin and Schulz (2006) proposed that ADHD is not due to dysfunction of the PFC,
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but rather due to subcortical neural dysfunction present during early development. As
such, symptom diminution is due to the degree which the developing PFC is able to
compensate for early neural deficit via its descending regulatory influence on more
caudal neural structures. Moreover, the delay aversion model (Sonuga-Barke et al., 1996)
and the cognitive-energetic model of ADHD (Sergeant, 2005) provide alternative
explanations for the symptoms and behaviours present in ADHD, with the former
implicating dysfunction to the neurobiological system linking present behaviour and
future reward/punishments, and the latter attributing the symptoms to dysregulation of
arousal centers.
The neuroimaging literature has implicated three primary neural circuits in
ADHD: fronto-striatal, fronto-cerebellar and fronto-limbic (Barkley, 2011d; Nigg &
Casey, 2005). Fronto-striatal functioning is thought to be important in the detection of
unpredicted reward or novel functioning and is associated with difficulties in response
suppression, ability to maintain concentration, working memory, planning, and
organization (Barkley, 2011d; Nigg & Casey, 2005). Alerting to, monitoring, and
detecting the mistiming of events is thought to rely on fronto-cerebellar circuitry, and is
associated with problems with timing, motor coordination and ‘timeliness of
behaviour’(Barkley, 2011d; Nigg & Casey, 2005). Finally, the fronto-limbic circuit has
also been implicated in ADHD, and is thought to underlie the detection and evaluation of
emotionally significant events or situations and reinforcement learning. In turn, this
circuit has been associated with the following symptoms: hyperactivity-impulsivity,
emotional impulsivity, motivational difficulties, and propensity to aggression (Barkley,
2011d; Nigg & Casey, 2005). These circuits are important in basic learning that forms the
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foundation for behavioural, cognitive and emotional control, as well as adjusting to
changes in the environment (Nigg & Casey, 2005). There is also recent evidence showing
that the trajectory of early abnormal brain development within ADHD is sex dependent.
For example, 4.5 and 8 year old boys with ADHD have less right-lateralized frontal alpha
asymmetry than typically developing boys, whereas girls with ADHD show a more rightlateralized asymmetry pattern than typically developing age-mates (Mahone & Wodka,
2008). Similarly, Hermens and colleagues (2005, as cited in Mahone & Wodka, 2008)
showed that irrespective of ADHD subtype, female adolescents with ADHD have focal
frontal increase in theta and electrodermal activity, while male adolescents with ADHD
show a widespread increase in theta activity. Whereas certain circuits have been
hypothesized to be impaired in ADHD, and neural abnormalities have been reported, it is
noteworthy to remember that there is no neuroanatomical profile that is consistent across
all individuals with ADHD (Miller, 2012).
As previously mentioned, DSM-5 criteria continue to fail to account for the
developmental changes in symptoms over time, although examples more appropriate for
older ages have been provided (APA, 2013a). This limits the identification of many
adolescents and adults who have ongoing and significant impairment due to ADHD
despite not meeting full diagnostic criteria for the disorder (Miller, 2012). This has also
been used to explain the lower persistance rates of the disorder into late adolescence and
adulthood (Barkley, Murphy, & Fischer, 2008). Relatedly, a common diagnostic issue is
whether the presence of less than the required number of symptoms warrants clinical
attention (Kalbag & Levin, 2005). The current polythetic model of ADHD, in which
various combinations of at least six symptoms are required for diagnosis, implies that
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ADHD symptoms form a continuum rather than marking a categorical boundary between
having and not having the disorder (Lubke et al., 2009). Moreover, for the symptoms to
be diagnostic of ADHD they have to be developmentally inappropriate and result in
impairment in major life activities (Barkley, Murphy & Fischer, 2008). By extension,
given that the ADHD symptoms reflect extremes on the developmental continuum that
are maladaptive and inconsistent with development level, it is possible to categorize all
individuals somewhere on this spectrum. That is, some have suggested that ADHD
reflects “an extreme on the quantiative manifestation of normal behaviour” (Acosta et al.,
2004, p. 3) allowing for the investigation of ADHD symptoms in a nonclinical sample.
Past research has examined the severity of ADHD symptoms in clinical (e.g., Barkley et
al., 2006) and nonclinical (e.g., Rodriguez & Span, 2008) samples, with more severe
symptoms of ADHD being positively correlated with impairment in daily life activities
and drinking habits, respectively.
Presently, there are no differences in recommendations for ADHD with respect to
diagnostic cut points according to the sex of the individual as per the DSM-5 (APA,
2013a). Further, the current set of symptoms neglects to mention certain central features
of ADHD, such as emotional impulsiveness, poor emotional self-regulation, and poor
working memory. Applying results from the UMass study of clinic-referred adults with
ADHD, Barkley, Fischer and Murphy (2008) encourage the use of nine symptoms based
largely on the construct of impulse control and attention in identifying adults with
ADHD, rather than the DSM-5 symptom list. Examples from this alternative list of
symptoms are: ‘often have poor follow through on promises or commitments I make to
others’, ‘start a project or task without reading or listening to instructions’ and ‘often
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have difficulty performing things in proper order’ (Barkley et al., 2008). Finally, the
current cutoffs and pattern of symptoms reflect research conducted mainly on males, and
thus may need to be adjusted accordingly to reflect female-specific symptom profiles
(Nadeau & Quinn, 2002; Rasmussen & Levander, 2009). A meta-analysis conducted by
Gaube and Carlson (1997) suggested that women have a different pattern of symptoms,
more dominated by inattention and less by hyperactivity, and present with higher rates of
internalizing symptoms (e.g., mood and anxiety problems) than externalizing symptoms
(e.g., conduct disorder) that are more common in males. Applying Barkley’s broadband
domains, meta-cognitive symptoms linked to dysfunction within the inattention domain
(e.g., emotional self-regulation, planning/problem solving, and working memory) may be
more affected in females with ADHD. Exemplifying the potential sex inappropriateness
of current diagnostic criteria, females are more likely to have greater impairment than
average when assessed using behaviour ratings of ADHD symptoms and yet not meet the
diagnostic threshold (Waschbusch & King, 2006, as cited in Mahone, 2010). Thus, the
relative neglect of incorporating these symptoms in the diagnosis of ADHD might
explain the sex differences in prevalence. Notably, some studies do not report these sex
discrepancies in the prevalence of ADHD inattention and hyperactivity/ impulsivity
symptoms (Biederman, Faraone, Monuteaux, Bober, & Cadogen, 2004; Rasmussen &
Levander, 2009), although their results may be due to sampling bias inherent in studies
utilizing self-referral/treatment-seeking individuals. Further, whereas Biederman and
colleagues (2004) report similar phenotypic features in both males and females with
ADHD, they do highlight that females with ADHD had significantly higher inattentive
scores than their male counterparts. In line with this finding, Fedele and colleagues
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(2012) report that college-aged ADHD females significantly endorse greater number of
inattentive and hyperactive symptoms than college males with ADHD. Moreover, they
show that even after controlling for symptom severity, emerging adult females with
ADHD report having greater levels of impairment.
Human Pubertal Development
The lack of a clear and consistent pattern of results across studies examining
symptom, behaviour, neuropsychological and neuroanatomical profiles of individuals
with ADHD can at least partly be attributed to developmental factors (Halperin & Schulz,
2006; Mahone, 2010). Adolescence marks a major developmental milestone, involving
dramatic changes in physical, psychological, and social maturity (Paus, Keshavan, &
Giedd, 2008). These developmental changes make adolescence a “period of vulnerability
and adjustment” (Casey, Jones, & Hare, 2008, p. 111). Reflecting this vulnerability, this
developmental period is a time of increased prevalence of several psychiatric illnesses
(e.g., mood disorders and eating disorders; Paus et al., 2008), and risky behaviours (e.g.,
drug and alcohol use and unprotected sex; Casey & Jones, 2010). Fundamental to the
changes occurring in adolescence are sex specific effects presumed to be caused, at least
in part, by the increase in secretion of circulating sex steroids with the onset of puberty
(Cahill, 2006).
Puberty, functionally coupled with adolescence, is defined as a period of elevated
secretion of gonadal steroid hormones. The onset of puberty marks the start of a
‘sensitive period’ in the development of and changes to the structural organization of the
nervous system (Sisk & Zehr, 2005; Zehr, Culbert, Sisk & Klump, 2005;). In humans,
pubertal maturation begins with hypothalamic gonadotropin releasing hormone (GnRH)
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secretion, which activates the hypothalamic-pituitary-gonadal (HPG) axis (Palmert &
Boepple, 2001; Sisk & Zehr, 2005). This period is “characterized by a gradual increase in
the frequency and amplitude of intermittent episodes of GnRH release” (Sisk & Zehr,
2005, p. 164). In turn, GnRH stimulates the production and secretion of luteinizing
hormone (LH) and follicle stimulating hormone (FSH), pituitary gonadotropins, which
promote release of sex steroid hormones (i.e., estradiol in females and testosterone in
males), and completion of gamete development (i.e., egg and sperm; Sisk & Foster, 2004;
Sisk & Zehr, 2005). The higher levels of estrogen and androgen in turn, trigger the
development of secondary sex characteristics (e.g., breast development in females and
growth of facial hair in males; Sisk & Zehr, 2005). It is important to remember that while
a hallmark of puberty is the production and secretion of gonadal steroids, puberty is not
only a gonadal event (Sisk & Zehr, 2005). Rather, it should be viewed as a “brain event”;
a period when sex hormones interact with the developing adolescent nervous system
(Sisk & Zehr, 2005, p. 164). In fact, puberty-related changes continue into the third
decade of life, thus corresponding to the lengthy maturation of the brain, in particular of
the frontal cortex that continues to develop well into the twenties (Gogtay et al., 2004;
Sisk & Zehr, 2005). Relatedly, the nervous system has a reciprocal influence on gonadal
development and maturation (Sisk & Zehr, 2005).
The developing adolescent brain is highly receptive to the effects of gonadal
steroid hormones. Circulating steroids (e.g., estradiol and progesterone) act in a timesensitive and graded manner to shape adolescent brain development during a protracted
process that spans more than a decade (Sisk & Zehr, 2005; Zehr et al., 2007). This
process is highly individualized. As such, variation in the age of puberty onset
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contributes to individual differences in developmental course and behavioral maturation
(Sisk & Zehr, 2005). Relatedly, differences in the timing of puberty will contribute to the
diversity of adult psychological characteristics, behaviours, and relative risks for
psychopathology (Sisk & Zehr, 2005; Zehr et al., 2007). Finally, given the permanent
organizational influence of gonadal hormones, effects dependent on the timing of puberty
are likely to be permanent and observable in adulthood (Sisk & Zehr, 2005; Zehr et al.,
2007).
The start of puberty in females is defined by the appearance of breast
development, with a median age of onset of 10.0 years (Papadimitriou et al., 2008; Parent
et al., 2003). Yet most studies examining the effects of timing of puberty onset typically
use age at menarche as the marker of puberty onset, which has a median age of onset of
12.5 years (Dorn & Biro, 2011; Parent et al., 2003). Although the physiology of puberty
is common to all individuals, its onset occurs across a wide range of ages in the normal
population (i.e., 11 years or earlier to 14 years or older; Palmert & Boepple, 2001; Parent
et al., 2003). Several pathologic conditions, such as central nervous system tumors or
systemic illnesses, can influence timing of puberty (Palmert & Boepple, 2001).
Moreover, the decrease in the age of pubertal onset over recent decades had been
attributed to changes in family structure (e.g., father absence), better nutrition, increased
obesity in childhood, and reductions in levels of childhood illness (DiVall & Radovick,
2009; Downing & Bellis, 2009). Yet, most variation in pubertal timing has no known
etiology, and much of this variation stems from differences in the reactivation of the HPG
axis (Dorn & Biro, 2011; Parent et al., 2003).
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Variation in sex steroid exposure has been used to explain sex differences in
neuroanatomy and cognitive function (Sisk & Zehr, 2005). For instance, it has been
reported that females undergo an earlier peak in brain volume (Lenroot et al., 2007),
greater growth in some structures over males (e.g., hippocampus; Sisk & Zehr, 2005),
and less white matter growth than males during adolescence (Lenroot et al., 2007; Perrin
et al., 2008). Given that circulating sex hormones influence virtually all mechanisms
involved in the remodeling of the adolescent brain (e.g., dendritic elaboration, synaptic
pruning, and axonal sprouting), it is not surprising that estrogen also plays a role in
modulating cognition in the developing human brain (Sisk & Zehr, 2005). Relevantly,
typical behavioural and cognitive changes noted in adolescence, such as risk-taking,
reward sensitivity, sensation/novelty seeking, and basic cognitive abilities have been
linked to pubertal maturation (Casey et al., 2008). For example, imbalance with the
frontolimbic circuitry has been used to account for the greater prevalence of risky
behaviours among adolescents and young adults, with only subcortical structures being
directly linked to pubertal maturation (Steinberg et al., 2008). Whereas the cognitive
functions most likely to be affected will be those linked to neuroanatomical areas with the
highest concentration of estrogen receptors, the scientific community remains uncertain
regarding the role of sex hormones in cognition.
Attention Deficit/Hyperactivity Disorder and Female Pubertal Development
As discussed above and in common with many neurodevelopmental disorders, the
prevalence of ADHD differs in males and females. In addition to the limitations inherent
in the DSM-5 nomenclature and proposed inadequacy of current rating scales in
capturing symptom severity among females, this sex discrepancy may, in part, be driven
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by hormonal influences. ADHD in females presents at a later onset and with more subtle
clinical symptoms, often of the predominantly inattentive subtype (Keltner & Taylor,
2002). The direct assessment of subtype differences is essential when investigating the
hormonal influences on ADHD symptom manifestation (Mahone, 2010). It has been
suggested that while females may be protected to some extent from the symptoms of
ADHD pre-puberty because of their earlier brain maturation, increased release of
estrogen with puberty, and corresponding increase in dopamine receptors, may lead to a
subsequent increase in ADHD symptoms (Fink, Rosie, Grace, & Quinn, 1996, as cited in
Nussbaum, 2012; Keltner & Taylor, 2002). That is, deficits in cognitive control may be
the result of the direct influence of sex hormones on the dopaminergic neural circuitry in
the nucleus accumbens, striatum, and prefrontal cortex (Martel, Klump, Nigg, Breedlove,
& Sisk, 2009). Animal models reveal female specific modulatory effects of estrogen and
progesterone on dopamine in the striatum and nucleus accumbens (Xia & Becker, 1994,
as cited in Martel et al., 2009). Similarly, higher levels of extracellular estrogen during
the estrous cycle in female rats are accompanied by greater dopamine release in the
striatum. It is also interesting to note that the amygdala, hippocampus, and orbital and
medial prefrontal cortices, and the hypothalamic-pituitary-adrenal axis are targets of
estradiol at puberty. Therefore, previous reports of remitting symptoms in ADHD into
adolescence and young adulthood may be more reflective of the trajectory of male
ADHD symptoms. Conversely, just when male symptoms begin to diminish, female
symptoms begin to be more apparent and reported (Keltner & Taylor, 2002). Relatedly, it
has been noted that increased hormonal fluctuations throughout the phases of the
menstrual cycle are associated with increased symptomatology (Nadeau, Littman, &
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Quinn, 2006). Further supporting the existence of a link between hormones, particularly
estrogen, and ADHD in females is the existence of ADHD comorbidities known to be
influenced by pubertal onset (e.g., eating disorders, anxiety, substance use and
depression; Zehr et al., 2007). That is, given that the manifestation of many of the known
common comorbidities in females with ADHD have been shown to be affected by
pubertal timing (Bijlenga et al., 2011; Klump et al., 2012; Westling, Andrews, Hampson,
& Peterson, 2008) it seems highly plausible that a correlation between pubertal onset and
ADHD exists. Finally, similar to the imbalance noted within the frontolimbic circuitry
used to account for the greater prevalence of risky behaviours among adolescents and
young adults (Steinberg et al., 2008), it is likely that the neural circuits implicated in the
inattentive symptoms and emotional dysregulation of ADHD (i.e., frontal-striatal and
frontal-limbic circuits) would also be affected by the puberty-dependent imbalance in
maturation between subcortical and cortical regions.
The Present Study
The literature reviewed above indicates that puberty is a key time for
neuroanatomical changes and that circulating sex steroids likely play a significant role.
Moreover, data suggest that circulating sex steroids modulate cognition, especially those
cognitive functions that are underpinned by anatomical structures richest in estrogen
receptors, such as the frontal cortex. The frontal lobes subserve various functions (e.g.,
affective regulation, attention/arousal, and impulse control), and the prefrontal area,
particularly involved in executive function, has been chiefly implicated in ADHD
(Nussbaum, 2012). There is growing evidence that subtle sex differences exist in the
symptom profile, neuropathology and clinical sequelae of ADHD, and that hormonal
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factors may play an important role in understanding ADHD in females. Yet, to date, there
has been little research on this topic. The present study sought to address the current gaps
in our understanding of how female pubertal maturation influences the extent of ADHD
symptoms in a nonclinical female sample. This was primarily an exploratory study.
Nevertheless, given the noted negative consequences of early puberty onset, such as
disordered eating and anxiety (Zehr et al., 2007), sexual risk taking, substance use and
anti-social behaviour (Downing & Bellis, 2009), it was predicted that aberrations from
typical pubertal onset, specifically early maturation relative to peers, would be associated
with elevated levels of ADHD symptoms, impairments in daily functioning, and
difficulties in emotion regulation. The findings from the study were aimed to add to the
general understanding of the relationship between puberty onset and executive
functioning. Further, the study was designed to add to our understanding of ADHD
prevalence rates among females, and the potential female-specific adolescent onset of
presenting symptoms.
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CHAPTER III
Methods
Design of Study
A quantitative, cross-sectional non-experimental design was used to examine the
predictive value of constructs associated with ADHD (e.g., executive functioning) on the
pubertal timing of typically developing female emerging adults. The study was
exploratory in nature, with limited past research to guide hypothesis generation. That
said, it was predicted that early pubertal onset would be associated with a greater number
of ADHD symptoms and related impairments.
Participants
An invitation to participate in the study was sent via the existing participant pool
system within the Department of Psychology at the University of Windsor. Participation
was open to females aged 18 to 25 years within the pool. There were no restrictions
based on race, socio-economic status, marital status, or neighbourhood of residence.
Individuals who reported being unable to read, speak or write in English were excluded
from participation. Finally, individuals with a self-reported history of traumatic brain
injury were also excluded.
At the outset, an estimated required sample size was determined by a power
analysis using the G-power program. A thorough literature review did not reveal prior
studies upon which a hypothesized effect size could be estimated. As such, a small effect
size value of 0.20 – 0.25 was chosen for the power analysis (Cohen, 1988). An alpha
level = 0.05, effect size = 0.20 to 0.25, power level = 0.80, and one covariate suggested a
sample size range of 158 to 244 participants. Correspondingly, the aim was to recruit
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approximately 200 participants, however, recruitment proved easier than expected and
information from a total of 254 female students was collected. One case was removed
from the analysis because the same participant completed the study at two different timepoints, for a final total of 253 participants.
The mean age of the total sample was 20.19 years (± SD = 1.69). As described in
greater detail below, participants were grouped based on timing of pubertal onset: early
(mean age ± SD = 20.58 ± 1.88), on-time (mean age ± SD = 20.09 ± 1.65) and late (mean
age ± SD = 19.98 ± 1.52). The majority of the sample (65.2%) self-identified as
Caucasian, with 9.88% Asian/Asian-descent, 9.09% African-Canadian/Black, 1.19%
Hispanic/Latino, 0.39% Aboriginal and 13.8% mixed-race or other. 78.3% of the sample
identified English as their primary language and 24.9% reported being able to speak
another language. In terms of marital status, 59.3% reported that they were single, 37.2%
were in a romantic relationship and 3.56% were married or cohabiting. In addition to
their studies at the university, 64.0% of the sample reported that they were employed
outside the home.
Parental education level was used as a proxy for socioeconomic status (SES).
Specifically, 69.9% of participants reported that their mothers completed more than 12
years of formal education (range = 1 to 22 years of formal education). A similar rate was
obtained for paternal education level, with 68.1% of participants reporting that their
fathers completed some level of post-secondary education (range = 8 to 22 years of
formal education). These rates are comparable to those reported by Statistics Canada in
2007 for the city of Windsor (62.04% of the population completed some level of postsecondary education; Statistics Canada, 2007).
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With regards to disclosure of relevant medical history, two participants identified
history of head injury accompanied with a loss of consciousness, seven participants
disclosed history of seizures, six participants identified that they had a diagnosis of a
learning disorder, and 15 participants reported having a current mental disorder (e.g.,
depression, anxiety). In an attempt to increase the generalizability of the findings, only
information provided by individuals with a reported history of head injury was excluded
from analysis, reducing the sample size to 251. Finally, it should be noted that the
pubertal onset groups, described in detail below, did not significantly differ on any of
these demographic variables.
Procedure
Once the participants arrived at the testing session and following the informed
consent process, they were asked to complete a series of questionnaires. They were
reminded that the session would last approximately one hour and that they would receive
one psychology course bonus point following the completion of the questionnaires. If
they agreed to continue, the following questionnaires were presented for completion: (1)
demographics form, (2) Pubertal Development Scale-Retrospective Version, (3) Barkley
Adult ADHD Rating Scale – IV (BAARS-IV), (4) Barkley Deficits in Executive
Functioning Scale (BDEFS), (5) Difficulties in Emotion Regulation Scale (DERS); (6)
Barkley Functional Impairment Scale (BFIS); (7) Risk-Taking Behavior questionnaire.
The participants completed the questionnaires in randomized order.
Measures
Demographics questionnaire. Demographic information was collected via a
form completed by all participants. The form requested general information about
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identity, including date of birth, race/ethnicity, marital status, parental education and
employment, handedness, height, weight, days since last menstrual period, in addition to
information about the participants’ medical (including current contraceptive use), and
developmental histories. Appendices contain copies of all questionnaires administered.
Pubertal Development Scale – Retrospective Version (PDS-RV). Participants
were asked to retrospectively answer questions on pubertal development using a modified
version of the Pubertal Development Scale (PDS) obtained from Dr. Cheryl Sisk at
Michigan State University. The original version of the PDS was designed for use with
adolescents to assess current pubertal development of a number of secondary sex
characteristics. Dr. Sisk and colleagues revised the modified version of the PDS in order
to assess timing of pubertal development in post-pubertal adults. Initially used with an
undergraduate sample at a large Midwestern university, Sisk and colleagues (2007) report
that the modified measure has good psychometric properties. Specifically, they reported
good internal consistency (α = 0.80 in females; α = 0.84 in males) and excellent testretest reliability (r = 0.87 for females; r = 0.83 for males). For most items, the
participants were asked to recall the timing of pubertal development relative to their peers
(i.e., “much earlier than others” (1), “somewhat earlier” (2), “about the same time” (3),
“somewhat later” (4), “much later” (5), or “do not know”). For other items, the
participants were asked to estimate the age at which an event occurred. The total PDSRV score was calculated by summing the scores from the following 6 items: “In general,
do you think your development was any earlier or later than most other girls?”; “Do you
think your first period was any earlier or later than most other girls?”; “Do you think your
breasts developed any earlier or later than most other girls?”; “Would you say that your
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growth in height was any earlier or later than other girls?”; “Would you say that your
growth of body hair was any earlier or later than other girls?”; “Would you say your skin
changed any earlier or later than other girls?” Smaller summed total scores reflected
earlier pubertal timing. All other items on the scale were informational, and were
included to exclude outliers or identify potential new covariates.
The mean PDS-RV total score for all participants was calculated to be 17.26 (SD
= 4.084), with the scores ranging from 6.00 to 29.0. The PDS-RV total score was also
examined per pubertal onset group, with the early pubertal onset group having a mean
score of 12.21 (SD = 1.966, range = 6.00 – 14.75), the on-time onset pubertal group
having a mean score of 17.22 (SD = 1.314, range = 15.00 – 19.18), and the late onset
pubertal group having a mean score of 22.74 (SD = 2.156, range = 19.89 – 29.00).
Cronbach’s alpha was calculated as a measure of internal consistency. This analysis
revealed a good alpha value of 0.81.
Barkley Adult ADHD Rating Scale-IV (BAARS-IV; Barkley, 2011a). Designed
with consideration of DSM-IV diagnostic criteria, the BAARS-IV is a self-report
questionnaire in which the participants were asked to report their current ADHD
symptoms. Specifically, with regards to the current symptoms interview, the participants
were asked to indicate to what extent each item described their behavior during the past
six months. The possible response for the questionnaire ranged from “Never/Rarely” (1)
to “Very Often” (4). A total ADHD score and symptom count was calculated by adding
up the scores for each item answered. From the BAARS-IV – current symptoms
questionnaire, 4 subscale totals were calculated related to the four recognized ADHD
symptom dimensions: Inattention, Hyperactivity, Impulsivity, and Sluggish Cognitive
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Tempo (SCT). The internal consistency, construct validity, discriminant validity and
criterion validity are all reported to be satisfactory (Barkley, 2011a).
Examination of the total scores for the BAARS-IV current symptoms questionnaire
for all study participants revealed a mean total score of 27.24 (SD = 6.498, range = 18.0 –
51.0), out of a possible maximum score of 108. Relatedly, analyzing the scores
independently for each pubertal onset group revealed that the early pubertal onset group
had a mean total score of 28.28 (SD = 6.846, range = 19.0 – 50.0), the on-time pubertal
onset group had a mean total score of 26.37 (SD = 5.860, range = 18.0 – 51.0), whereas
the late pubertal onset group had a mean total score of 27.95 (SD = 7.229, range = 18.0 –
49.0). Table 1 displays the mean, standard deviation and range of scores for each
subscale separately per pubertal onset group. The internal consistency for all 27 items
was excellent, with an alpha value of 0.90. Calculation of Cronbach’s alpha for the
inattention, hyperactivity, impulsivity and sluggish cognitive tempo subscales revealed
alpha values of 0.82, 0.59, 0.69, and 0.87, respectively.
Barkley Deficits in Executive Functioning Scale (BDEFS; Barkley, 2011b).
The BDEFS is an 89-item Likert-type rating scale designed to evaluate the variety
of behavioural, emotional, and motivational symptoms linked to executive functioning
deficits. More specifically, this self-report measure aims to capture self-regulation ability
within five domains: Self-Management to Time, Self-Organization/Problem Solving,
Self-Restraint (Inhibition), Self-Motivation and Self-Regulation of Emotion.
Correspondingly, the scale provides a global measure of deficits in executive functioning,
as well as subscale scores for each of the five domains. Individuals are asked to indicate
how frequently they experienced each of the problems in the past six months, with
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possible responses ranging from “Never or Rarely” (1) to “Very Often” (4). Developed
for use in a variety of settings, including research, the measure has been shown to have
satisfactory reliability and validity (Barkley, 2011b).
The mean BDEFS total score for all participants was 148.90 (SD = 34.64, range =
91 – 273), out a possible maximum total score of 356. Table 1 includes the score statistics
for each BDEFS subscale for all participants and per pubertal onset group. Internal
consistency for the total score was evaluated to be excellent, with an alpha value of 0.97.
Relatedly, the Cronbach’s alpha values for each subscale were also evaluated to be
satisfactory (Self-Management to Time = 0.94; Self-Organization/Problem = 0.94; SelfRestraint = 0.85; Self-Motivation = 0.84; and Self-Regulation of Emotion = 0.92).
Difficulties in Emotion Regulation Scale (DERS; Gratz & Roemer, 2004). The
DERS is a self-report measure designed to evaluate clinically significant difficulties in
emotion regulation. The measure was originally developed with a large undergraduate
sample at the University of Massachusetts – Boston (Gratz & Roemer, 2004), and has
since been used with substance abusers and other clinical populations (Gratz et al., 2008).
Participants were asked questions reflecting difficulties in four domains of emotion
regulation, including (1) awareness and understanding of emotions; (2) acceptance of
emotions; (3) the ability to use goal-directed behaviour and control impulsive behaviour
when having negative emotions, and (4) ability to use effective emotion regulation
strategies. They were asked to indicate how often the items apply to them, with responses
ranging from “almost never” (1) to “almost always” (5). The total DERS score was
calculated by summing the scores for all 36 items, with possible scores ranging from 36
to 180. Gratz and Roemer (2004) report preliminary findings suggesting that the DERS
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has high internal consistency, good test-retest reliability, and adequate construct and
predictive validity.
The mean DERS total score for all study participants was 81.80 (SD = 21.98), with
the scores ranging from 39.0 to 153.0. Please refer to Table 1 for the mean, standard
deviation and ranges for the score breakdown per pubertal onset group and per DERS
subscale. The internal consistency for all 36 items of the DERS was excellent, with an
alpha value of 0.94. Cronbach’s alphas were also calculated for each DERS subscale,
revealing the following: Nonacceptance of Emotional Responses subscale (α = 0.89),
Difficulties Engaging in Goal-Directed Behaviour subscale (α = 0.91), Impulse Control
Difficulties (α = 0.88), Lack of Emotional Awareness (α = 0.84), Limited Access to
Emotion Regulation Strategies (α = 0.89), and Lack of Emotional Clarity (α = 0.82).
Barkley Functional Impairment Scale (BFIS; Barkley, 2011c). The BFIS is a
self-report measure that was used to ask participants to rate the degree of psychosocial
impairment they believe they are experiencing in 15 major domains of adult life activities
(i.e., home-family, home-chores, work, social- strangers, social-friends, community
activities, education, marriage/cohabiting/dating, money management, driving, sexual
relations, daily relations, daily responsibilities, self-care routines, health maintenance,
and childrearing; Barkley, 2011c). Participants were asked to indicate how much
difficulty they have functioning effectively in each of the major life activities during the
past six months, with possible responses ranging from “Not at all” (0) to “Severe” (9). A
summed total score for the questionnaire was calculated by adding up the individual item
scores, excluding those items that were answered “Does not apply” (99). The scale is
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reported to have satisfactory internal consistency, test-retest reliability, and validity
(Barkley, 2011b).
The mean impairment score for all participants was 2.071 (SD = 1.583) out of a
possible maximum mean impairment score of 9. The scores for the scale ranged from 0 to
7.69. See Table 1 for the mean impairment score, standard deviation and range for each
pubertal onset group. Cronbach’s alpha for the BFIS is excellent in this sample, with an
alpha value of 0.96.
The Risk-Taking Behavior Questionnaire (RTBQ). Participants were asked to
complete a self-report measure of their engagement in and frequency of specific risky
behaviours across five domains, including driving, drugs/alcohol/cigarettes, law breaking,
family, and sexual behaviour. This is an unpublished measure originally developed to
survey risk-taking behaviour in a related study of younger adolescents and has been used
extensively with university students. Preliminary analyses suggest that this measure has
adequate psychometric properties (Miller, White, Knezevic, Ostojic, & Niemasik,
manuscript submitted for publication). Participants were asked how frequently they
engaged in the listed behaviours over the past six months, with possible responses
ranging from zero (“Never”) to four (“11 or more times in the past six months”). The
final of the sexual behaviour items, the total lifetime number of sexual partners, was
scored slightly differently (0 = no sexual partners, 1 = 1-2 sexual partners, 2 = 3-5 sexual
partners, and 3 = 6 or more sexual partners. Despite the fact that the RTBQ is
differentiated into five domains, only the summed total score is interpreted. The summed
total score for the RTBQ was calculated by adding up the individual item scores, with a
possible maximum score of 99.
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The mean RTBQ total score for all participants was calculated to be 14.63 (SD =
9.144), with the scores ranging from 0.00 to 44.0. The RTBQ total score was also
examined per pubertal onset group, with the early pubertal onset group having a mean
score of 16.61 (SD = 9.757, range = 1.00 – 42.0), the on-time onset pubertal group having
a mean score of 13.76 (SD = 8.635, range = 0.00 – 42.0), and the late onset pubertal
group having a mean score of 14.34 (SD = 9.386, range = 0.00 – 44.0). Internal
consistency, evaluated by calculating Cronbach’s alpha using all 23 items, was adequate
with an alpha value of 0.79.
Data Analyses
All analyses were performed using the Statistical Package for Social Science
(SPSS) for Mac, Version 21.0. Prior to conducting the main analyses the data were
assessed for patterns of missingness and missing data was subsequently imputed using
the expectation-maximization procedure. A one-way multivariate analysis of covariance
(MANCOVA) was initially chosen as the statistical test of choice with puberty onset as
the independent variable with three factor levels: early, on-time, and late puberty onset.
MANCOVA was chosen because it was speculated that given the related content of the
questionnaires the outcome variables would likely be correlated. Further, the number of
days since the last menstrual period was suspected to be a covariate (K. Milne, personal
communication, March, 2012). Days since last menstrual period was initially chosen as
the covariate because fluctuating sex hormone levels during the menstrual cycle have
been shown to affect performance in a wide range of domains, including fine motor
performance (Bayer & Hausmann, 2012), prepulse inhibition (Kumari et al., 2010),
learning and memory (Gasbarri et al., 2008), inhibitory output control (Colzato, Hertsig,

27

van den Wildenberg, & Hommel, 2010), attention (Colzato, Pratt, & Hommel, 2012), and
female dominance motivation and behaviour (Stanton & Schultheiss, 2007). Moreover, it
has been argued that ignoring menstrual cycle status of female respondents may bias selfreporting and clinician’s judgments about numerous syndromes and disorders (Endicott
& Shea, 1989). This continuous variable was split into two groups: less than or equal to
14 days or more than 14 days since last menstrual period; with former corresponding to
the follicular phase of the menstrual cycle and the latter, the luteal phase (Barnett et al.,
2004; Butt, 1979). Notably, however, this variable was found to not be associated with
the outcome variables, and thus was removed from all further analyses.
Relatedly, as described below in greater detail, before proceeding with the
analysis, verification of the statistical assumptions for MANCOVA was done; revealing
that the assumptions were not met (described below). All subsequent attempts to remedy
this problem were unsuccessful. As a result, the decision to proceed with a different
statistical test (i.e., multinomial logistic regression) was made. Multinomial logistic
regression was chosen because this statistical procedure is thought to be robust to
violations of normality and homogeneity of variance-covariance matrices, and makes no
assumption that the predictors have to be linearly related (Tabachnich & Fidell, 2007, p.
437). Further advantage of this technique is that it allows for the selection of a reference
group for all comparisons (Field, 2009, p. 301). In contrast to the MANCOVA, however,
the outcome variable in the multivariate logistic regression was timing of puberty, with
three categories: early, on-time, and late puberty onset, whereas the subscale and
composite totals on the questionnaires served as the predictors. As was done by Zehr and
colleagues (2007), quartiles for the summed total score of pubertal development scale
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were used to categorize early (lowest quartile), on-time (middle-two quartiles), and late
(highest quartile) pubertal onset. Next, logistic regression analysis was conducted to
allow for a direct comparison between the early pubertal onset group and the on-time
pubertal group. Finally, this was followed up by descriptive analyses. A p < 0.05 was
selected as the statistical significance level for all analyses. This is the standard alpha
value utilized most often by researchers (Field, 2009, p. 281) and was considered
appropriate given the exploratory nature of the study. Interestingly, Tabachnick & Fidell
(2007; p. 455) report that Hosmer & Lemeshow (2000) suggest using a less stringent cutoff, in the range of 0.15 to 0.20, for the inclusion of a variable in order to avoid
erroneously removing a predictor that may be involved in a suppressor effect. Notably,
however, as described below the entry method chosen for the step-wise logistic
regression is designed to minimize Type II error.
Missing Data
Investigation of the absence of data, including the pattern of missingness was
done in order to address the fact that missing data may bias the analysis and result
findings (McKnight, McKnight, Sidani, & Figueredo, 2007). Computing the proportion
of missing data using the sparse matrix method yielded an overall item-non-response rate
of 0.184%, whereas calculation of the response rate using the complete case method for
the 253-participant dataset was 18.9%. Correspondingly, the sparse-matrix-to-completecase ratio, was calculated to be 0.00976, signifying that the average amount of data
missing per incomplete case is approximately 0.976%. Further, the messiness index was
found to be 0.813, indicating a messy missing data pattern in which each participant has
her own pattern of missing data (McKnight et al., 2007, p. 109). Importantly, a messy
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missing data pattern suggests that the data is missing completely at random (MCAR).
Closer inspection of the individual outcome questionnaires (i.e., BAARS-IV,
BDEFS, DERS, and RTBQ) further supported the conclusion of a scattered pattern of
missingness, with each questionnaire having an overall item non-response rate less than
1%. It should be noted that apart from one participant not completing the entire DERS,
there were no cases in which participants left more than a few items incomplete per
questionnaire. With regards to the Puberty Development Scale-Retrospective version
(PDS-RV), the 6 items used to calculate the total PDS-RV score, and the PDS-RV item
reflecting age of first menstruation were analyzed for missingness. It should be noted that
data was considered missing if the individual responded “Don’t Know” or if they left the
item blank. The overall item non-response rate was calculated to be 3.29% with the
greatest number of missing items concentrated on items pertaining to growth of body hair
relative to peers (14.2%) and timing of skin changes relative to peers (7.87%). Pertaining
to the three demographic variables used to impute PDS-RV missing values, race, weight
and height, with the latter two used to calculate a Body Mass Index score, only one case
was missing in the sample for each variable.
To examine the impact of the missing data and to ensure that the missingness was
not conditional on the other variables in the data set, Little’s MCAR test was conducted
(Missing Completely at Random; Little, 1988). Given that the null hypothesis for the test
is that the data are MCAR, the non-significant result from the Little’s MCAR test (x2
=7868.937; df = 7830; p = 0.376) suggested that the data are at least Missing at Random
(MAR), and therefore, the missingness is not dependent on the other values in the data set
(Little, 1988). In line with the visual inspection of the missing data, and taking into
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account the existing selection bias in the sample (i.e., sample consisted of those
participants who voluntarily signed up for the study and completed the questionnaires),
the conclusion that the data are likely at least missing at random is justified.
Imputation of Missing Data
Expectation-Maximization (EM) was used to replace missing values. As per
Tabachnick and Fidell (2007, p. 71), EM method provides the “simplest and most
reasonable approach to imputation of missing data”, when there is evidence that the data
are at least missing at random. As such, given the minimal amount of missing data, and
evidence that the values are missing at random, use of EM was deemed appropriate. To
obtain less biased estimates of the missing data, imputation of missing data was done
separately for the PDS-RV and the outcome measures. Missing PDS-RV items were
imputed using the key PDS-RV items (i.e., PDS items: 1, 2, 4, 6, 13, 17, and 21), a
calculated body mass index (BMI) score and race. The latter two variables were chosen
because both the BMI score and race have been associated with the timing of pubertal
onset (Kaplowitz, Slora, Wasserman, Pedlow, & Herman-Giddens, 2001; Lee et al.,
2007). Inclusion of the other PDS-RV items (i.e., PDS items: 8, 11, 15, 19, 23) led to a
failure to converge after 100 iterations. Consequently, these items were not included
because the lack of convergence would lead to unstable estimates. With regards to
imputing data for the outcome measures using EM, the missing values for the BAARS-IV
Current scale, BDEFS, BFIS and DERS were done together. The RTBQ items were not
included because the EM algorithm conducted with these items failed to converge after
25 iterations, even though Little’s MCAR test was not significant. Again, given that the
lack of convergence would lead to unstable estimates, missing values for the RTBQ were
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imputed independently of any other variables in the dataset. The individually imputed
datasets were combined and all subsequent analyses were conducted using this new
dataset. Notably, however, although the results presented reflect analysis done using the
imputed datasets, given the small amount of missing data the original and imputed
datasets were very similar.
Analysis of the Assumptions of MANCOVA
Prior to conducting the main analyses as planned using a MANCOVA, the data
were first examined to see if the assumption for MANCOVA were met. Although not a
direct assumption of MANCOVA, examination of univariate normality for the
independent variable, PDS-RV total score measured as a continuous variable, was done
to ensure that break-down into groups based on quartiles would be justified and unbiased.
The assumption of normality for the PDS-RV total score was assessed using tests of
normality and examination of kurtosis and skewness values. Although, the KolmogorovSmirnov test was significant (p<0.000), the Shapiro-Wilks test was not (p = 0.096), nor
did kurtosis and skewness values exceed ±2 and ±3, respectively. Further, examination of
the histogram and Q-Q plots suggested a normal distribution for the PDS total score.
The assumption of multivariate normality for the outcome variables was assessed
through examination of the skewness and kurtosis values, the Shapiro-Wilk statistic, and
bivariate scatterplots. Given that a necessary, but not sufficient, condition for
multivariate normality to hold, is to ensure that observations on each dependent variable
must follow a normal distribution in each group, univariate normality was first examined
for each variable independently (personal communications, D. Jackson, January 2013;
Tabachnick & Fidell, 2007, p. 78). This is especially important if inference is an aim
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(Tabachnick & Fidell, 2007, p. 79). Examination of univariate normality for the BAARSIV current scale by visual inspection of Q-Q plots and histogram showed a distribution
with a positive skew. This conclusion was supported as both tests of normality were
significant at the p<0.001 level. A positive skew was also observed for all subscale totals.
Attempts to correct normality by conducting square root and logarithmic transformations
as recommended by Tabachnick and Fidell (2007; p. 88) were not successful. Similarly,
examination of univariate normality for the BDEFS and BFIS also revealed non-normal
distribution of scores; a conclusion supported by significant tests of normality (i.e.,
Kolmogorov-Smirnov (p<0.001) and Shapiro-Wilks tests (p<0.001)) and visual
inspection of the histograms and Q-Q plots. Further, the assumption of normality was
also not met for all of the associated subscale totals. In contrast to the BAARS-IV current
scale, conducting a logarithmic transformation did improve normality for the BDEFS
total score as indicated by a non-significant Kolmogorov-Smirnov test (p = 0.200) and
visual inspection of the histogram. It should be noted, however, that the Shapiro-Wilks
test was still significant for the total score (p = 0.030) after the logarithmic
transformation, and neither transformation improved normality for the BDEFS subscales.
Relatedly, performing a square root transformation did improve normality for the BFIS as
indicated by non-significant Kolmogorov-Smirnov (p = 0.200) and Shapiro-Wilks tests
(p<0.119), and visual inspection of the histogram and normal Q-Q plots. Notably,
logarithmic transformation yielded a negatively skewed distribution. With regards to the
DERS, examination of normality for the total score revealed a slight positive skew, and
tests of normality supported conflicting conclusions (Kolmogorov-Smirnov (p = 0.075)
and Shapiro-Wilks (p = 0.002)). Moreover, evaluation of the kurtosis and skewness

33

values showed that they did not exceed their respective cutoffs of ±2 and ±3. Notably,
visual inspection of the histogram and Q-Q plots did suggest that the distribution was
positively skewed. Again, in attempt to fix this slight deviation from normality, square
root and logarithmic transformations were done (Tabachnick & Fidell, 2007, p. 88) The
square root transformation made the distribution normal as indicated by non-significant
tests of normality: Kolmogorov-Smirnov (p=0.200) and Shapiro-Wilks (p = 0.489).
Further, as depicted on the Q-Q plots and histogram, the data distribution appeared
normal. No outliers were identified on the box-plot. In line with this finding, the z scores
for the DERS total score before and after the square root transformation did not exceed
±3.29. Further, examination of normality for each PDS-RV group showed that the
assumption of normality was met. In contrast, the subscales on the DERS were not
normally distributed, and both square root and logarithmic transformations were not
successful in correcting this deviation from normality. Finally, the assumption of
univariate normality was also not met for the RTBQ, and conducting square root and
logarithmic transformations did not help improve normality. Therefore, given that
univariate normality was violated in nearly all cases, a necessary condition for meeting
the assumption of multivariate normality, the assumption of a multivariate normal
distribution was also violated (Stevens, 2009). Fortunately, Stevens (2009) notes that this
assumption is robust with respect to type I error.
The assumption of homogeneity of variance-covariance was tested using Box’s M
test. Box’s M was significant for all predictor variables, indicating that this assumption
was violated. Box’s M value remained significant after removal of the outliers, further
supporting the retention of all usable cases. Notably, this test is very sensitive to
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violations of normality. Further, it is conditionally robust if the group sizes are equal or
approximately equal (largest/smallest <1.5; Stevens, 2009), which was not the case in the
present analysis. Therefore, one can be confident in the conclusion that this assumption
was also violated.
To ensure that the assumption of independence of observations was met, the data
collection process was designed to minimize any chance that the responses for one person
would affect the ratings on the measures for another. For instance, participants were
always spaced far enough apart while completing the questionnaires to not allow for
copying of responses, and they were not given the opportunity to communicate or share
their responses with one another. That said, the shared school environment participants
have may limit complete independence of observations. Further, each case reflects the
responses of a unique participant. In the one case that a participant completed the study
twice, the responses from their second time was removed from all analyses. Therefore, it
can be argued that the assumption of independence of observation was met. This is
especially important given that the assumptions of multivariate normality and
homogeneity of variance-covariance matrices were not met.
Finally, the assumption of adequate sample size was assessed. Including all
identified outliers, and after removing the repeated case and the two individuals who
reported a history of head injury, a final sample of 251 was used for subsequent analyses.
Using quartiles to create pubertal timing categories led to unequal group sizes, with the
early pubertal onset group having 64 participants, the on-time pubertal onset group had
127 participants, and the late pubertal onset group had 60 participants. The total sample
size/number of variables ratio was calculated to be 41.8:1, which met the criteria that the
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ratio should be at least 20:1 (Stevens, 2009). Thus, the assumption of adequate sample
size holds, and one can be more confident in the interpretation of the results. It should be
noted that the late pubertal onset group was removed for the logistic regression analysis
described below, bringing the final sample size for this analysis to 191 participants.
Attempting to improve normality, identification and removal of outliers and
influential observations was done by entering all variables of interest in a linear
regression model (personal communication, D. Jackson, May 2013). In order to detect
univariate outliers, standardized residuals were examined. Using z = ± 3.29 standard
deviations from the mean as the cut-off, no outliers were detected. Mahalanobis distance
(D2) was calculated in order to detect multivariate outliers. Using the D2 cut-off value of
49.728 (df = 23, k = 23, α = 0.001), 11 cases were detected. These 11 outliers were
removed and the assumption of multivariate normality and homogeneity of variances was
reassessed. The assumption of multivariate normality was still violated, and no
significant improvements in skewness and kurtosis values were observed following the
removal of the cases. Similarly, bivariate scatterplots revealed no change in normality,
and thus the outliers on y were retained. Finally, no influential observations were found in
the data, as no Cook’s distance value came close to 1. Further justifying keeping these
cases, when data is not normally distributed it is difficult to identify if those cases are not
from the population of interest.
Justification for Conducting Multinomial Logistic Regression and Logistic
Regression
As a result of violating both the assumption of normality and homogeneity of
variance, and given that the only assumptions met were adequate sample size and
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independence of observations, conducting a parametric test, such as a MANCOVA, is not
justifiable. Consequently, the analysis needed to be conducted using either a nonparametric test, or a test not requiring the strict adherence to these assumptions. Thus,
multinomial logistic regression, given that it is robust to violations of normality and
homogeneity of variance-covariance matrices, was chosen (Tabachnick & Fidell, 2007, p.
437). Notably, logistic regression does assume independence of observations, linearity,
and absence of multicollinearity (Tabachnich & Fidell, 2007, p. 443; Field, 2009, p. 273).
As described above, the assumption of independence of errors/observations was met.
Similarly, for all but two predictors (i.e., BDEFS Self Management of Time Score and
BDEFS Self-Regulation of Emotion Score) the assumption of linearity of the logit was
met. This assumption was evaluated by examining “if the interaction term between the
predictor and its log transformation was significant” when entered in the logistic
regression model (BDEFS Self Management of Time Score: p = 0.036 and BDEFS SelfRegulation of Emotion Score: p = 0.035; Field, 2009, p. 273). Finally, testing for
multicollinearity revealed no violation of this assumption as the tolerance values for all of
the predictors were not less than 0.1, nor were VIF values greater than 10 (Field, 2009, p.
297).
In addition to being more flexible than other techniques, multinomial logistic
regression allows for the selection of a reference group for all comparisons (i.e., on-time
pubertal onset; Field, 2009, p. 302), as does logistic regression. Stepwise multinomial
logistic regression utilizes statistical criteria to include and remove predictors from the
equation (Tabachnick & Fidell, 2007, pp. 454). Although criticized for this, this
methodology serves a good purpose in screening or hypothesis generating (Tabachnick &
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Fidell, 2007, p. 454), which is appropriate given the exploratory nature of this study.
Although underutilized in social science research, both multinomial and binary logistic
regression is a very useful method when the outcome variable is categorical and the
predictors are continuous and/or categorical (Davis & Offord, 1997). Stepwise is
defensible when conducting analyses in an area where there is limited or no existing
research (Field, 2009, p. 272). Moreover, it allows for the selection of those variables that
are significantly associated with pubertal onset, while concurrently removing predictors
that have less of an impact. When using a stepwise method, the backward method is
preferred over the forward method because it allows for the detection of suppressor
effects, and thus is less likely to cause a Type II error (Field, 2009, p. 272). Finally, with
regards to the test statistic to be used in the stepwise method, the likelihood ratio method
is preferred, given that the Wald statistic may produce inaccurate results under certain
conditions (Field, 2009, p. 272). For these reasons, multinomial logistic regression and
logistic regression were both done using the step-wise backward entry method, with the
likelihood ratio statistic used as the criterion for comparing the models with and without
the predictor. This procedure was later followed-up with step-wise forward entry
method, to see if the same set of predictors have significant score statistics.
Multinomial logistic regression was done first because it allowed for the
comparison of both the early and late pubertal onset groups to the on-time pubertal onset
group. This analysis revealed that any significant differences on the administered
questionnaires only existed between the early and on-time pubertal onset groups.
Consequently, and in concordance with the hypothesis predicting the negative
consequences of early pubertal onset, this analysis was followed up with logistic
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regression, comparing these two groups. This analysis paralleled the findings from the
multinomial logistic regression and were the findings that were interpreted.
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CHAPTER IV
Results
Logistic Regression Model
For each logistic regression analysis, interpretation of the goodness-of-fit test
using the “-2 Log-Likelihood Statistic” was performed in order to assess how well the
logistic regression model fit the data. Further, examination of the B-value
(unstandardized regression coefficient), odds ratio, and significance of the Wald statistic
(measure of the unique contribution of each predictor) was done to determine how well
each predictor in the model fit the data (Field, 2009, p. 284-89). In this study, the
potential explanatory variables were entered in groups based on their corresponding
questionnaires. That is, all subscales of one questionnaire were entered independently of
the subscale totals corresponding to the other questionnaires. Relatedly, in order to avoid
issues of multicollinearity, symptom count totals and total scores were not entered along
with the matching subscale totals in the same logistic regression analysis. Instead,
symptom counts corresponding to the same questionnaire were entered together, whereas
all questionnaire total scores were entered and analyzed together to determine whether or
not they are significant predictors in the model. Finally, all variables that were identified
as significant in the previous analyses were entered in the same logistic regression
analysis.
Outcome Variable in the Logistic Regression Analysis
The outcome variable for all of the logistic regression analyses was pubertal
timing, determined by the participant’s score on the PDS-RV questionnaire. As
described above, pubertal onset had three factor levels: early, on-time and late pubertal
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onset, and quartiles for the summed total score of pubertal development were used to
categorize early (lowest quartile), on-time (middle-two quartiles), and late (highest
quartile) pubertal timing. For the purposes of comparing early to on-time pubertal onset
using logistic regression, pubertal onset was operationalized as a dichotomous variable,
with those characterized as having on-time pubertal onset given a value of 0 and those
identified as having early pubertal onset given a value of 1. This coding was chosen in
order to aid in interpretation by labeling the on-time pubertal onset category as the
reference group. As such, the odds ratio was interpreted at the ratio of the probability of
membership in the early pubertal onset group occurring and the probability of this not to
occur when the predictor variable increases by one. After removing two participants from
the analysis because they disclosed having a head injury resulting in a loss of
consciousness, the number of participants categorized in the on-time and early pubertal
onset groups was 127 and 64, respectively.
Independent Variables in the Logistic Regression Analysis
Barkley Adult ADHD Rating Scale – IV: Self-report – Current Symptoms.
The four subscale totals of the BAARS-IV self-report of current symptoms questionnaire
(i.e., Inattention, Hyperactivity, Impulsivity and Sluggish Cognitive Tempo) were entered
in step-wise backward entry logistic regression model. Assessment of model fit was done
by examining the change in the maximum likelihood statistic when the predictors were
added to the model (i.e., examination of the model chi-square statistic). This showed that
the addition of the four subscales did not significantly improve model fit over the model
when only the constant was included, although the chi-square value did approach
significance (initial -2 log likelihood = 243.608; Goodness of fit = 240.037; χ2 (1) =
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3.571, p = 0.059). Interestingly, the Hosmer-Lemeshow test produced a non-significant
chi-square value (χ2 (8) = 2.913, p = 0.940), indicating an improvement in the model, as
a good model produces a non-significant chi-square value (Tabachnick & Fidell, 2007, p.
459). With regards to the unique contribution of each predictor, none of the variables
were identified as making a significant contribution to the prediction of pubertal timing
membership, although as depicted in Table 2, the Wald statistic for the Inattention
subscale total approached significance. Notably, the odds ratio is similar to those
predictors that were significant. Thus, the effect size is comparable despite the nonsignificance. Additional measures of effect were provided with the Cox and Snell’s
measure (R2 = 0.019) and Nagelkerke’s adjusted value (R2 = 0.026). It is important to
note that the Cox and Snell value takes into account sample size and underestimates
effect size as it cannot achieve a maximum value of one (Tabachnick & Fidell, 2007, p.
460). Finally, follow-up analysis using a step-wise forward entry logistic regression
method did not produce a model.
In contrast to the non-significant finding noted above, when symptom counts for
the four subscales were entered in a logistic regression analysis (stepwise backward
entry), the current Inattention Symptom count score was identified as a significant
predictor. Examination of the model chi-square statistic revealed an improvement in
model fit with the addition of this variable (initial -2 log likelihood=243.608; Goodness
of fit=237.989; χ2 (1) = 5.619, p = 0.018), and the Hosmer-Lemeshow test produced a
non-significant chi-square value (χ2 (2) = 1.403, p = 0.496). Inspection of the measures
of effect sizes, Cox and Snell (R2 = 0.029) and Nagelkerke’s (R2 = 0.040) values
suggested stronger effects. Further, entering the variables as symptom counts instead of
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totals improved classification accuracy to 68.1%. Table 3 includes regression coefficients
in the final model.
As depicted in Table 3, the odds of correctly predicting group membership are
increased by 27.0% with the addition of the Inattention Symptom count to the model. In
short, as the inattentive symptom count increases, the more likely one will have had an
earlier pubertal onset.
Barkley Deficits in Executive Functioning Scale. As was done for BAARS-IV
scales, the five BDEFS subscale totals (i.e., Self-Management to Time, SelfOrganization/Problem Solving, Self-Restraint, Self-Motivation, and Self-Regulation of
Emotion) were simultaneously entered in the logistic regression analysis, using the
backward step-wise method. A significant model chi-square statistic (initial -2 log
likelihood = 243.608; Goodness of fit = 237.928; χ2 (1) = 5.680, p = 0.017) revealed an
improvement in model fit with the addition of the Self-Regulation of Emotion subscale
total to the model. Further, the Hosmer-Lemeshow test produced a non-significant
finding (χ2 (8) = 6.581, p = 0.582) indicating an improvement in the model (Tabachnick
& Fidell, 2007, p. 459). With the inclusion of the Self-Regulation of Emotion subscale
total the model classified 66.5% of participants correctly. Table 4 includes regression
coefficients in the final model.
As illustrated in Table 4, as the variable Self-Regulation of Emotion score
increases by one, participants are 1.053 times more likely to be classified in the early
pubertal onset group. That is, the odds of correctly predicting classification increased by
5.3%. Cox and Snell’s measure (R2=0.029) and Nagelkerke’s adjusted value (R2=0.041)
provide measures of effect size. Follow-up analysis using step-wise forward entry method
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confirmed that Self-Regulation of Emotion subscale score is making a significant
contribution to the prediction of the timing of pubertal onset.
The BDEFS form also allows for the calculation of an executive-function (EF)
symptom count that is a measure of the number of items that were answered with a
sufficiently rare response suggesting the presence of clinical symptoms of an executive
functioning deficit. Unlike the BAARS-IV scales, the BDEFS does not have symptom
counts for the individual subscales. As such, only the EF symptom count was entered as a
continuous variable in the logistic regression analysis (step-wise: backward entry).
Assessment of model fit after the addition of this variable suggested an improvement in
model fit (initial -2 log likelihood=243.608; Goodness of fit=238.941; χ2 (1) = 4.667, p =
0.031). Further, as shown in Table 5, the variable was identified as a significant predictor,
although its odds ratio was relatively small. With the addition of this variable the
accuracy of the classification improved to 67%, with the odds of correctly predicting a
participant’s timing of pubertal onset increased by 2.6%. This suggests that a participant
is more likely to have had an early pubertal onset if they reported having a higher EF
symptom count.
Difficulties in Emotion Regulation Scale. The DERS yields a total score and six
subscale scores: (1) Nonacceptance of emotional responses (Nonacceptance), (2)
Difficulties engaging in goal directed behaviour (Goals), (3) Impulse control difficulties
(Impulse), (4) Lack of emotional awareness (Awareness), (5) Limited access to emotion
regulation strategies (Strategies), (6) Lack of emotional clarity (Clarity). The six subscale
totals were entered in the step-wise logistic regression analysis using the backward entry
method. Examination of model fit revealed a significant model chi-square statistic (initial
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-2 log likelihood = 243.608; Goodness of fit = 239.251; χ2 (1) = 4.357, p = 0.037)
indicating an improvement in model fit with the addition of the Impulse subscale total to
the model. Relatedly, the non-significant Hosmer-Lemeshow test (χ2 (7) = 7.867, p =
0.344) also suggested an improvement in the model (Tabachnick & Fidell, 2007, pp.
459). With the inclusion of the Impulse subscale total the model classified 66.5% of
participants correctly. As depicted in Table 6, the odds ratio for the Impulse subscale is
1.070, indicated that the odds of correctly predicting classification increases by 7.0%
with the addition of this variable. In other words, as the Impulse subscale score increases
by one, participants are 1.070 times more likely to be classified in the early pubertal onset
group. Cox and Snell’s measure (R2=0.023) and Nagelkerke’s adjusted value (R2=0.031)
provide measures of effect size. Again, follow-up analysis using a step-wise forward
entry method also identified the Impulse subscale as making a significant contribution to
improving model fit of the data. Table 6 includes regression coefficients in the final
model.
All Total Scores. The total scores from all six questionnaires were entered in the
step-wise logistic regression analysis using the backward entry method. Examination of
model fit revealed a significant model chi-square statistic (initial -2 log likelihood =
239.192; Goodness of fit = 231.491; χ2 (2) = 7.701, p = 0.021) indicating an
improvement in model fit. Further suggesting an improvement in the model with the
addition of the predictors is the non-significant Hosmer-Lemeshow test finding (χ2 (8) =
12.305, p = 0.138; Tabachnick & Fidell, 2007, p. 459). In fact, with the inclusion of the
Barkley’s Functional Impairment Scale total and the Risk Taking Behaviour
Questionnaire total scores the overall accuracy of the classification improved to 67.7%.
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Table 7 includes regression coefficients in the final model.
As displayed in Table 7, using the backward-entry method neither predictor left in
the final model had a significant Wald statistic, although both approached significance.
This is especially the case for the BFIS Total score as it had an odds ratio of 1.210,
indicating that the odds of correctly predicting classification increases by 21% with the
addition of this variable. Notably, when the same set of predictors were entered in a
forward step-wise entry method, the BFIS total score was identified as making a
significant contribution to the prediction of group membership. That is, an individual’s
score on the BFIS significantly predicted whether they were classified in the early or ontime pubertal onset group (see Table 8).
As indicated by the odds ratio displayed in Table 8, as the BFIS increases by one
unit, participants are 1.239 times more likely to be classified in the early pubertal onset
group. Thus, the odds of correctly predicting classification increased by 23.9%.
For three of the six questionnaires used in the study it was possible calculate
symptom counts: BAARS-IV Childhood symptom count, BAARS-IV Current symptom
count and BDEFS-EF symptom count. These were entered in the step-wise logistic
regression analysis using the backward entry method. Examination of model fit following
the addition of these variables revealed an improvement in model fit as illustrated by a
significant model chi-square statistic (initial -2 log likelihood = 243.608; Goodness of fit
= 237.223, χ2 (1) = 6.385, p = 0.012). Estimates of effect size were provided with the
Cox and Snell’s measure (R2 = 0.033) and Nagelkerke’s adjusted value (R2 = 0.046).
Further, inspection of the classification table revealed that the adjusted model was able to
correctly classify 67.5% of participants. Table 9 includes regression coefficients in the
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final model.
As shown in Table 9, the odds ratio for the BAARS-IV current total symptom
count is 1.182, indicated that the odds of correctly predicting classification increases by
18.2% with the addition of this variable. That is, as the number of BAARS-IV current
symptoms increases by one, participants are 1.182 times more likely to be classified in
the early pubertal onset group than the on-time pubertal onset group. Follow-up analysis
using a step-wise forward entry method confirmed this finding.
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CHAPTER V
Discussion
Review of Research Question
The aim of the current study was to investigate how the timing of female pubertal
maturation is associated with the extent of ADHD symptoms and related impairments in
a non-clinical female emerging adult sample. Despite the growing evidence that
circulating sex hormones during puberty may help explain the subtle sex differences that
exist in the symptom profile, neuropathology and clinical sequelae of ADHD, there is
limited research in this area. Consequently, this work was primarily an exploratory study,
with minimal past research to guide hypothesis generation. That said, it was predicted
that early pubertal onset would be associated with higher levels of ADHD symptoms,
difficulties in emotion regulation, impairments in daily functioning, and risk-taking
behaviour.
Overview of Research Findings
Using logistic regression models, significant contributory factors were identified
to classify those who reported having an earlier pubertal onset relative to their peers.
Overall, the present findings suggest that early puberty is associated with more current
symptoms of ADHD and greater impairment on a variety of ADHD-related factors.
These factors may be categorized in four domains: (1) deficits in attention, (2) difficulties
in emotion regulation, (3) psychosocial impairment, and (4) risky behaviour. As may be
predicted from existing literature suggesting that ADHD females present with more
inattentive rather than hyperactive/impulsive symptoms (Gaube & Carlson, 1997;
Nussbaum, 2011), early pubertal timing in this non-clinical female sample was not
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associated with current levels of hyperactivity and impulsivity, nor with self-regulation
difficulties within domains such as self-restraint and self-motivation.
General Discussion
Deficits in attention. The present findings suggest that pubertal onset is
associated with current level of inattentive symptoms, such as having difficulties in
sustaining attention, difficulty following instructions, experiencing frequent forgetfulness
in daily activities, and losing things. Specifically, as the count of current inattentive
symptoms increases, the odds of an individual reporting they matured earlier than their
peers increase. This finding provides empirical support for the influence of pubertal
timing on deficits in inattention, and is consistent with the hypothesis that the rise in
inattention symptoms may be the consequence of the changes in the hormonal milieu
during puberty; a developmental trajectory that may be unique to females (Nussbaum,
2012). This may be especially important if considered in light of the fact that many adult
females who exhibit impairments in attention are often misdiagnosed as having other
psychopathology (e.g., dysthymia when inattentive symptoms are present alongside low
levels of arousal; Nadeau & Quinn, 2002a, 2002b as cited in Nussbaum, 2012; Wender,
Wolf & Wasserstein, 2001), and comorbidities for which a role of puberty onset has been
suggested, such as Major Depressive Disorder (Martel et al., 2009).
Difficulties in emotion regulation. Exploration of the association between the
timing of pubertal onset and deficits in emotion regulation revealed a significant
contribution of emotion regulation factors in predicting pubertal onset group
membership. Specifically, as individuals reported greater deficits in self-regulation of
emotion, by endorsing items such as “Overreact emotionally”, “Having trouble calming
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myself down once I am emotionally upset”, and “Unable to manage my emotions in order
to accomplish my goals successfully or get along well with others”, the more likely they
would be to be classified in the early pubertal onset group. Similarly, reporting more
impulse control difficulties (e.g., disclosing having difficulty controlling behaviours and
emotions when upset) was associated with higher odds of having matured earlier relative
to other females. Again, in line with these findings, affect lability and emotional
impulsivity have been implicated in ADHD (Barkley, 2009; Barkley & Murphy, 2010;
Sobanski et al., 2010), and emotional regulation difficulties have been linked to the rise
in internalizing symptoms in girls with ADHD post-puberty (Lee & Hinshaw, 2006).
These findings help highlight the importance of considering emotional impulsivity and
poor emotional self-regulation as central features of ADHD in females. There continues
to be a need for further studies examining deficits in emotional regulation in an ADHD
sample (Surman et al., 2013).
Psychosocial impairment. Deficits in psychosocial functioning are a hallmark of
many mental disorders, including ADHD (Biederman et al., 1993). Correspondingly,
those who reported higher levels of psychosocial impairment across several domains
were more likely to experience puberty earlier than their age-mates. Graber and
colleagues (2004) demonstrate a similar finding, showing that girls with earlier pubertal
onset report having poorer adjustment than girls who met pubertal milestones ‘on-time’.
Specifically, they reported difficulties with the quality of their interpersonal relationships,
having smaller social support networks and lower life satisfaction. This is interesting
given that there is overwhelming evidence that both children and adults with ADHD
show impairments in numerous areas, such as school/work and in interpersonal
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relationships (Barkley et al., 2002); a finding also noted for females with ADHD
(Biederman et al., 1999). Specifically, Biederman and colleagues (1999) report impaired
scores in global, academic and family functioning for girls with ADHD. Further, this is in
line with the finding from the present study, showing a significant positive correlation
between the total current number of ADHD symptoms (r = 0.452, p< 0.001) and mean
functional impairment. The under-identification of females with ADHD means that many
girls with considerable functional difficulties will continue to have their difficulties
unacknowledged and untreated. This finding supports the need for clinicians to pay close
attention to impairments in several domains of psychosocial functioning, especially in
girls who begin to mature earlier than others.
Risky behaviour. In line with previous reports noting the negative consequences
of early puberty onset on adolescent risk-taking behaviour (Downing & Bellis, 2009),
early pubertal onset were associated with greater report of risk-taking behaviour in this
sample of young adults. This finding corroborates previous cross-sectional and
longitudinal studies that have linked early maturation with higher prevalence of risky
behaviour, including unhealthy substance use and risky sexual behaviour (Downing &
Bellis, 2009; Witt, 2007). For instance, Biehl and colleagues (2006) report an association
between early pubertal maturation and higher alcohol use and heavy drinking in late
adolescence and young adulthood. In contrast, a study exploring the relationship between
the age at menarche with current smoking, and heavy use of alcohol and other drugs in
the past year among 14-15 year-old Canadian girls sampled from the National
Longitudinal Survey of Children and Youth, revealed no association (Al-Sahab, Ardern,
Hamadeh, & Tamim, 2012). Interestingly, Wichstrom (2001) reports the use of the PDS
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over other measures of pubertal timing reveals higher correlations between pubertal
timing and adolescent substance use. The present study adds to the current literature by
providing evidence to suggest that early pubertal timing is also associated with risky
behaviour in domains that have been explored to a lesser extent, such as risky driving
behaviour or rule breaking. It has been argued that elevations in hormone secretion at
puberty alter reward circuits during adolescence, influencing reward seeking behaviour,
such as alcohol consumption (Witt, 2007). Reciprocally, drinking behaviour during postpubertal development in turn influences brain development, including the effects of sex
hormones, via mechanisms not yet understood (Witt, 2007). It is important to note,
however, that the relationship between pubertal timing and subsequent substance use has
been explained with reference to other hypotheses, such as the Deviance Hypothesis
(Petersen & Taylor, 1980, as cited in Wichstrom, 2001).
Interpreting Current Findings Within a Neurobiological Conceptual Framework.
It has been argued that, in contrast to reports that ADHD is more common in
males than in females during childhood, there is less of a discrepancy in adult ADHD
prevalence rates between males and females (Nussbaum, 2012). This increase in
representation of females with ADHD in adolescence and adulthood suggests a potential
organizational influence of sex hormone exposure during puberty (Nussbaum, 2012). In
turn, these organizational effects of sex hormones on psychological symptoms and
behaviour, which are dependent on the timing of puberty onset, should be observable
post-puberty (Sisk & Zehr, 2005; Zehr et al., 2007). This assertion is supported by the
current findings suggesting that alterations in brain development as a consequence of
earlier hormonal exposure during adolescence are associated with ADHD related
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symptomology and psychosocial functioning in emerging adulthood. Relatedly, as an
individual reports an increasing number of clinical symptoms of an executive functioning
(EF) deficit, the odds of them having an earlier pubertal onset increase. “Hormonedependent remodeling” of neural circuitry during puberty has been suggested as the
potential explanatory mechanism (Sisk & Zehr, 2005; Zehr et al., 2007).
As described above, deficits in the prefrontal cortex and/or neural circuits linking
the prefrontal cortex to subcortical regions have been implicated in ADHD (Biederman,
2005; Nigg & Casey, 2005). Notably, these brain regions are associated with
catecholamine neurotransmitter systems (e.g., dopamine) that have also been linked to
ADHD and have been the target of stimulant medication (Biederman, 2005; Halperin &
Shulz, 2006). Increase in circulating sex hormones, specifically estrogen, is thought to
induce an increase in the number of dopamine receptors (Fink, Rosie, Grace, & Quinn,
1996 as cited in Nussbaum, 2012). This increase in dopamine receptors with puberty is
hypothesized to at least partly explain the increase in symptoms post-pubertal adolescents
and young adults (Nussbaum, 2012). In animal models, male rats show an increase in
dopamine receptors pre- and post-puberty, and approximately half-fold decrease by
adulthood, whereas females rats do not display this pattern of over-production and
elimination of dopamine receptors (Andersen & Teicher, 2000). Andersen & Teicher
(2000) suggest that the lack of pre-programed elimination of dopamine receptors in the
striatum in ADHD females may explain why there is persistence of problems into
adulthood. Further, they hypothesize that delayed pruning of dopamine receptors in the
pre-frontal cortex, may explain why motoric symptoms of ADHD tend to diminish postpuberty, whereas attentional difficulties persist (Andersen & Teicher, 2000). This has
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been suggested as an explanation for the gender differences in the timing of symptom
presentation and clinical sequelae. Importantly, these neural circuits develop into early
adulthood, and it is likely that sex hormones influence the structural and neurochemical
development in many other complementary ways (i.e., influencing synaptogenesis,
dendritic elaboration, and myelination), via mechanisms not yet completely understood
(Sisk & Zehr, 2005).
In applying this explanation for the present findings, it is important to remember
that early puberty onset needs to be considered within the context of family history, racial
and/or ethnic differences, pre-pubertal body mass index (BMI), geographic and
meteorological context, social environment, and medical history (Posner, 2006; Wales,
2011). That is, other factors may mediate or moderate the observed relationship between
the timing of puberty and ADHD-related symptoms and behavioural impairments in
adulthood. In fact, when current BMI, which is usually associated with pre-pubertal BMI
(Must et al., 2005), was entered into each logistic regression model, the effect size for
each model increased while the individual predictors listed above remained significant.
Although a hormonal mechanism may play a part in explaining both the current
findings and gender differences in ADHD symptom onset and presentation, alternative
explanations are also worth noting. For instance, reports of higher adult ADHD
prevalence rates among females may be a reflection of poor symptom recognition among
girls by parents and teachers and the inadequacy of current diagnostic criteria in
identifying females with ADHD (Nussbaum, 2012). Other neurobiological mechanisms,
independent of hormonal influences, may also be responsible, such as neurogenesis and
synaptogenesis. Goldstein and Gordon (2003; as cited in Nussbaum, 2012) write that this
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increase in prevalence post-puberty may be suggestive of a “less severe form of the
disorder in younger females”. Further, it is important to remember that the changing
social norms and expectations accompanying pubertal onset may also play a role in the
current presentation of ADHD symptoms and related impairments. It has been argued
that early maturing girls have fewer resources to successfully adjust to the changes
accompanying puberty than later maturing girls, and as a consequence are more likely to
experience emotional and behavioural problems (Mendle, Turkheimer, & Emery, 2007).
For instance, early maturing girls are more susceptible to early substance use (Bratberg,
Nilsen, Holmen, & Vatten, 2005; Wiesner & Ittel, 2002), sexual behaviour (Flannery,
Rowe, & Gulley, 1993), delinquency (Mendle et al., 2007), In turn, these experiences
may affect current symptom presentation via their direct or indirect impact on the
development of the nervous system post-puberty.
Limitations of the Present Study
The findings from the present study are limited by several factors. First, by using
a non-clinical university sample, one is limited in the conclusions that are warranted with
regards to the nature of ADHD in females and in the generalizability of the findings.
Notably, however, use of only clinic-referred ADHD females may also not be justified
given that it has been argued that clinic-referred female ADHD samples may not be
representative of the typical manifestation of ADHD in females (Gaub & Carlson, 1997).
Thus, future studies should aim to capture as large of a community sample of females
with ADHD as possible. Further limiting generalizability, the sample in the current study
did not have an equal representation of all race/ethnic groups to allow for an accurate
evaluation of any racial/ethnic differences that have been associated with pubertal timing,
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but the breakdown accurately represented the local population. Second, it may be argued
that the use of a retrospective, self-report measure does limit the accuracy of the
conclusions that can be made. Yet, there is evidence to suggest that retrospective
estimates of pubertal timing are relatively accurate (Dubas, Graber, & Petersen, 1991).
Relatedly, while collateral information was not collected to corroborate self-report of
symptoms, Barkley, Knouse and Murphy (2011) report moderate to high agreement
between adult self-report and others-report with regards to current symptoms and
impairment. Third, the use of a cross-sectional design does not warrant causational
conclusions regarding the effect of pubertal timing on ADHD symptoms in emerging
adulthood. Finally, the choice of using logistic regression analysis in this study may be
methodologically confusing given that one is retrospectively predicting from current
symptoms. It is worth noting, however, that other studies examining factors predictive of
early puberty have utilized this technique (Downing & Bellis, 2009).
Unique Contributions of the Present Study
There are several strengths of the present research worth noting. First, the
literature is limited with studies exploring the relationship between pubertal timing and
ADHD related symptoms and impairments later in life. In fact, the author is unaware of
any similar studies that have been conducted within the Canadian context. Curbing this
gap is important in addressing an overlooked public health concern (i.e., the lack of
clinical and research attention paid to symptom presentation and functional difficulties of
females with ADHD). Second, as per the expert recommendations (personal
communication with Russell Barkley, October 2011), the study takes advantage of selfreport behaviour rating scales that have been suggested to be more sensitive in capturing
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female-specific difficulties (Mahone, 2010). Similarly, the measure of pubertal timing
used in the study incorporates multiple developmental aspects of pubertal status, and not
just age at first menarche, providing a more comprehensive estimation of pubertal onset.
Third, although logistic regression analysis is commonly used in cross-sectional
epidemiological studies, many fewer studies in the social sciences take advantage of this
technique. This statistical method proved to be an appropriate technique in this
circumstance when the violation of several statistical assumptions made the use of other
techniques unjustified.
Clinical Implications
The findings from the current study lend support for the argument that there is a
need for further research examining gender differences in ADHD across the lifespan.
Notably, although it does not speak directly to the need for modifying diagnostic
thresholds, or using gender-specific diagnostic criteria to address potential gender
differences, it does highlight the potential influence of sex hormones in symptom
presentation and clinical sequalae of ADHD. This research is especially warranted when
considered in light of the fact that relative to males with ADHD, adult females with
ADHD report having a greater number of problems, yet fewer assets (Arcia & Conners,
1998, as cited in Rasmussen & Levander, 2009). Further, exploration of the impact of
early pubertal onset on cognitive and psychosocial function is justified given that there is
a trend toward girls beginning puberty at earlier ages (Al-Sahab, Ardern, Hamadeh, &
Tamim, 2010; Gluckman & Hanson, 2006; Tanner, 1991, as cited in Posner, 2006). By
improving our current understanding of the presentation of ADHD in females, we might
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be better able to identify and improve quality of care given to females with ADHD, and
thus potentially aiding in the establishment of sex specific interventions.
Conclusion and Future Directions
The present findings do not provide evidence for a causational relationship
between pubertal timing and ADHD symptoms in emerging adulthood. They do,
however, provide preliminary evidence for a relationship between these two variables.
That is, hormonal-dependent organizational influences during puberty seem to be
associated with ADHD symptoms and behaviours later in life, with earlier pubertal onset
linked to more deficits in attention, emotion regulation, and psychosocial functioning,
and greater reports of risky behaviour. It should be noted, however, that none of these
symptoms are specific to ADHD, and many individuals with other psychopathology will
present with some subset of these symptoms and impairment. Nevertheless, these
findings provide support for a potential organizational effect of sex hormones during
pubertal development.
The study sheds light on the impact of early puberty and its findings help pave the
way for future research. Given that this is an unexplored research area, the possibilities
for future studies are numerous. This includes conducting a longitudinal study examining
symptom presentation across development, with special attention given to girls who
experience precocious puberty. This would not only overcome the limitations of a crosssectional design, but would also alleviate any limitations that may be due to the use of
retrospective measures of pubertal onset. Relatedly, it is important to remember that
organizational effects of sex hormones are not necessarily exclusive or independent of the
potential transient activational effects of sex steroids. As such, future work should
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examine symptom presentation during pubertal development, allowing for a better
understanding of both short-term and long-term effects of pubertal timing.
Despite the fact that ADHD symptoms reflect extremes on the developmental
continuum allowing for the investigation of ADHD symptoms in a nonclinical sample,
use of a clinical sample would more directly address the research question. This would
require access to a community sample of females with ADHD, which has been noted to
be a difficult population to recruit. Relatedly, it would be interesting to examine if there
are any subtype differences with regards to the influence of sex hormones during puberty.
Future studies could also add to the growing literature by examining or
controlling for the influence of factors known to impact pubertal timing, such prepubertal BMI, socioeconomic status, and number of childhood illnesses (Downing &
Bellis, 2009). These factors may mediate or moderate the identified relationship. Further,
future studies should examine the interplay between hormonal influence and growing
social demands on symptom presentation in emerging adulthood. It would also be
interesting to further explore how the identified deficits in attention and emotion
regulation in emerging adulthood contribute to the reported psychosocial functional
impairments and higher risk taking behaviour in females with ADHD.
Overall, the present research aids in the understanding of the impact of
differential pubertal timing and the role hormonal exposure during puberty may play in
explaining the differences in gender prevalence rates of ADHD and symptom profiles.
Future studies are needed to further examine the influence that elevations in sex
hormones during puberty may have in increasing ADHD symptom presentation, and how
and to what extent these effects are permanent and observable in adulthood.
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Table 1
Mean, Standard Deviation and Range for Each Questionnaire by Pubertal Onset Group
Questionnaire
PDS-RV
(maximum score = 30)

BAARS-IV Current
Symptoms Total Score
(maximum score = 108)

BAARS-IV Current
Inattention Subscale Score
(maximum score = 36)

BAARS-IV Current
Hyperactivity Subscale
Score
(maximum score = 20)

BAARS-IV Current
Impulsivity Subscale Score
(maximum score = 16)

BAARS-IV Current
Sluggish Cognitive Tempo
Subscale Score
(maximum score = 36)

BDEFS Total Score
(maximum score = 356)

BDEFS Self-Management
to Time Subscale Score
(maximum score = 84)

BDEFS SelfOrganization/Problem
Solving Subscale Score
(maximum score = 96)

BDEFS Self-Restraint
Subscale Score
(maximum score = 76)

Pubertal Onset
Group

Mean

Standard
Deviation

Range

Early
On-time
Late
All Participants

12.21
17.22
22.74
17.26

1.966
1.314
2.156
4.084

6.00 – 14.8
15.0 – 19.2
19.9 – 29.0
6.00 – 29.0

Early
On-time
Late
All Participants

28.28
26.37
27.95
27.24

6.846
5.860
7.229
6.498

19.0 – 50.0
18.0 – 51.0
18.0 – 49.0
9.00 – 31.0

Early
On-time
Late
All Participants

14.83
13.69
14.27
14.12

4.410
3.574
4.313
3.995

9.00 – 31.0
9.00 – 26.0
9.00 – 31.0
9.00 – 31.0

Early
On-time
Late
All Participants

7.672
7.080
7.733
7.387

2.055
2.062
2.503
2.187

5.00 – 14.0
5.00 – 14.0
5.00 – 17.0
5.00 – 17.0

Early
On-time
Late
All Participants

5.781
5.606
5.950
5.730

2.027
1.691
2.086
1.877

4.00 – 12.0
4.00 – 14.0
4.00 – 14.0
4.00 – 14.0

Early
On-time
Late
All Participants

17.44
16.72
17.23
17.03

5.363
4.547
5.261
4.929

9.00 – 32.0
9.00 – 30.0
9.00 – 33.0
9.00 – 33.0

Early
On-time
Late
All Participants

154.84
145.10
150.61
148.90

38.17
32.41
34.83
34.64

97.9 – 268.0
91.0 – 273.0
94.0 – 214.9
91.0 – 273.0

Early
On-time
Late
All Participants

40.52
37.88
40.77
39.08

12.89
10.63
11.39
11.60

21.0 – 74.0
21.0 – 72.0
24.0 – 68.0
21.0 – 74.0

Early
On-time
Late
All Participants

41.69
40.04
40.77
40.64

13.59
11.32
11.39
11.92

25.0 – 94.0
24.0 – 81.0
24.0 – 68.0
24.0 – 94.0

Early
On-time
Late
All Participants

30.29
28.43
28.53
28.93

7.128
6.300
6.749
6.648

19.0 – 50.0
19.0 – 48.0
19.0 – 48.0
19.0 – 50.0
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Early
On-time
Late
All Participants

18.23
17.23
17.68
17.59

5.349
4.694
4.070
4.733

11.9 – 39.0
12.0 – 37.0
12.0 – 28.0
12.0 – 39.0

Early
On-time
Late
All Participants

24.11
21.52
23.53
22.66

8.169
6.280
7.761
7.232

13.0 – 47.0
13.0 – 43.4
13.0 – 42.0
13.0 – 47.0

(maximum score = 180)

Early
On-time
Late
All Participants

85.02
79.13
84.05
81.80

22.86
20.35
23.94
21.98

46.0 – 153.0
39.0 – 146.0
41.0 – 142.0
39.0 – 153.0

DERS Nonacceptance of
Emotional Responses
Subscale Score

Early
On-time
Late
All Participants

13.25
13.06
13.80
13.29

5.798
5.269
5.967
5.564

6.00 – 30.0
6.00 – 29.0
5.06 – 30.0
5.06 – 30.0

Early
On-time
Late
All Participants

16.22
15.49
16.08
15.82

4.971
5.315
4.906
5.125

5.00 – 25.0
5.00 – 25.0
6.00 – 25.0
5.00 – 25.0

Early
On-time
Late
All Participants

12.00
10.50
11.60
11.14

5.401
4.150
5.578
4.881

6.00 – 28.0
6.00 – 28.0
6.00 – 28.0
6.00 – 28.0

Early
On-time
Late
All Participants

14.45
13.26
13.81
13.70

4.731
4.405
4.882
4.614

6.00 – 25.0
6.00 – 30.0
6.00 – 26.0
6.00 – 30.0

Early
On-time
Late
All Participants

18.38
16.57
17.81
17.33

7.704
6.286
6.664
6.781

8.00 – 36.0
8.00 – 35.0
8.00 – 31.0
8.00 – 36.0

Early
On-time
Late
All Participants

10.72
10.24
10.94
10.53

3.627
3.394
3.880
3.573

6.00 – 21.0
5.00 – 19.0
5.00 – 25.0
5.00 – 25.0

BFIS Mean Impairment
Score
(maximum score = 9)

Early
On-time
Late
All Participants

2.408
1.860
2.158
2.071

1.867
1.393
1.589
1.583

0.00 – 6.90
0.00 – 7.08
0.00 – 7.69
0.00 – 7.69

RTBQ Total Score

Early
On-time
Late
All Participants

16.61
13.76
14.39
14.63

9.757
8.635
9.386
9.144

1.00 – 42.0
0.00 – 42.0
0.00 – 42.0
0.00 – 44.0

BDEFS Self-Motivation
Subscale Score
(maximum score = 48)

BDEFS Self-Regulation of
Emotion Subscale Score
(maximum score = 52)

DERS Total Score

(maximum score = 30)

DERS Difficulties
Engaging in Goal-Directed
Behaviour Subscale Score
(maximum score = 25)

DERS Impulse Control
Difficulties Subscale Score
(maximum score = 30)

DERS Lack of Emotional
Awareness Subscale Score
(maximum score = 30)

DERS Limited Access to
Emotion Regulation
Strategies Subscale Score
(maximum score = 40)

DERS Lack of Emotional
Clarity Subscale Score
(maximum score = 25)

(maximum score = 99)
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Table 2
Regression Coefficients for Model Variables: BAARS-IV Current Symptoms
B (SE)

Wald

df

P

95% CI for Odds Ratio
Lower Odds Ratio Upper
0.997
1.076
1.162

Inattention Score
0.073 (.039) 3.541 1 0.060
Constant
-1.729 (.580) 8.871 1 0.003
2
Note. R = 0.940 (Hosmer & Lemeshow), 0.019 (Cox & Snell), 0.026 (Nagelkerke).
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Table 3
Regression Coefficients for Model Variables: BAARS-IV Current Symptom Counts
B (SE)

Wald

df

P

95% CI for Odds Ratio
Lower Odds Ratio Upper

Inattention
Symptom
0.239 (.102) 5.492 1 0.019
1.040
1.270
1.552
Count
Constant
-0.911 (.185) 24.309 1 0.000
Note. R2 = 0.496 (Hosmer & Lemeshow), 0.029 (Cox & Snell), 0.040 (Nagelkerke).
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Table 4
Regression Coefficients for Model Variables: Barkley’s Deficits in Executive Functioning
Scale
B (SE)

Wald

df

P

95% CI for Odds Ratio
Lower Odds Ratio Upper

Self-Regulation of
0.051 (.022) 5.569 1 0.018 1.009
1.053
1.099
Emotion Score
Constant
-1.856 (.526) 12.448 1 0.000
2
Note. R = 0.091 (Hosmer & Lemeshow), 0.026 (Cox & Snell), 0.036 (Nagelkerke).
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Table 5
Regression Coefficients for Model Variables: Barkley’s Deficits in Executive Functioning
Scale – Symptom Count
B (SE)

Wald

df

P

95% CI for Odds Ratio
Lower Odds Ratio Upper

Executive
Function
0.025 (.012) 4.602 1 0.032 1.002
1.026
1.050
Symptom Count
Constant
-1.013 (.221) 21.038 1 0.000
2
Note. R = 0.163 (Hosmer & Lemeshow), 0.024 (Cox & Snell), 0.033 (Nagelkerke).
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Table 6
Regression Coefficients for Model Variables: Difficulties in Emotion Regulation Scale
B (SE)

Wald

df

P

95% CI for Odds Ratio
Lower Odds Ratio Upper
1.004
1.070
1.141

Impulse Score
0.068 (.033) 4.313 1 0.038
Constant
-1.444 (.402) 12.939 1 0.000
Note. R2 = 0.344 (Hosmer & Lemeshow), 0.023 (Cox & Snell), 0.031 (Nagelkerke).
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Table 7
Regression Coefficients for Model Variables: Total Scores (Backward entry)
B (SE)

Wald

df

P

95% CI for Odds Ratio
Lower Odds Ratio Upper
0.995
1.210
1.472
0.995
1.030
1.065

BFIS Total Score
0.191 (.100) 3.657 1 0.056
RTBQ Total Score 0.029 (.017) 2.852 1 0.091
Constant
-1.565 (.362) 18.711 1 0.000
2
Note. R = 0.138 (Hosmer & Lemeshow), 0.040 (Cox & Snell), 0.056 (Nagelkerke).
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Table 8
Regression Coefficients for Model Variables: Total Scores (Forward entry)
B (SE)

Wald

df

P

95% CI for Odds Ratio
Lower Odds Ratio Upper
1.022
1.239
1.502

BFIS Total Score
0.214 (.098) 4.776 1 0.026
Constant
-1.171 (.265) 19.459 1 0.000
2
Note. R = 0.568 (Hosmer & Lemeshow), 0.025 (Cox & Snell), 0.035 (Nagelkerke).
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Table 9
Regression Coefficients for Model Variables: Total Scores – Symptom Counts
B (SE)

Wald

df

P

95% CI for Odds Ratio
Lower Odds Ratio Upper

BAARS-IV
Current Total
0.167 (.068) 6.006 1 0.014 1.034
1.182
1.351
Symptom Count
Constant
-0.984 (.199) 24.339 1 0.000
Note. R2 = 0.058 (Hosmer & Lemeshow), 0.033 (Cox & Snell), 0.046 (Nagelkerke).
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APPENDICES
APPENDIX A
Demographic Information
Participant’s Name:
Participant’s Student Number:

_____ Current Year:

Major: ___________

Home Address:
Home Phone:
Cell Phone:
Email:
Name/phone number for another person who will know how to find you if we cannot
reach you:
May we contact you again in the future for other studies? YES _______ NO ______
Instructions: The items in this questionnaire address issues pertaining to your personal
identity, medical history, and family background. For questions that include numbered
choice options, please circle the number(s) that best describes your answer. Other items
will provide you with space(s) to provide a written response. Be sure to read each item
carefully, and direct any questions to a member of the research staff. Please try to
answer each item as best you can, however, if you feel uncomfortable with any question,
you do not need to answer it. Please know that your answers will be kept completely
confidential. Please do not write your name on any page but this front page. (This cover
page will be detached and stored with your consent forms to protect your
confidentiality.)

(FOR PROJECT USE ONLY – ID # ________________________)
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(PROJECT USE ONLY – ID # _________________)
1. DEMOGRAPHIC INFORMATION
Date of Birth (MM/YY): ___/___
Age ______

Today’s Date (DD/MM/YY): ___/___/___

Race/ethnic background: (please circle)
[1] ABORIGINAL
[2] ASIAN OR ASIAN DESCENT
[3] HISPANIC/LATINO
[4] NON-HISPANIC BLACK OR AFRICAN DESCENT
[5] NON-HISPANIC WHITE OR CAUCASIAN
[6] OTHER/MIXED (please describe)
[7] PREFER NOT TO ANSWER
Marital status: (please circle)
[1] SINGLE
[2] IN A ROMANTIC RELATIONSHIP
[3] MARRIED/CIVIL UNION/COHABITING
[4] WIDOWED
[5] PREFER NOT TO ANSWER
Body Weight: ___________ (POUNDS (lb) / KILOGRAMS (kg))
(please circle one)
Height: ___________
Days since last menstrual periods: _______ days
Typical length of menstrual period: ______ days
Are you currently pregnant? (please circle) [1] NO [2] YES
Is there a chance you could be pregnant? (please circle) [1] NO

[2] YES

Do you write with your right or left hand? (please circle)
[1] RIGHT
[2] LEFT
[3] BOTH
Are you employed? (please circle) [1] NO

[2] YES

IF YES, what is your job title ________________________________________
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(PROJECT USE ONLY – ID # _________________)
2. HOUSEHOLD INFORMATION/FAMILY INFORMATION
Total number of household members (including you): _______
# of children (under 18 years of age): _______
Parent Information:
RELATION TO
YOU
PARENT
Please indicate if
BIOLOGICAL, STEP,
FOSTER, OR
ADOPTIVE

AGE

# of adults: _______

OCCUPATION

HIGHEST
GRADE
COMPLETED

Did your mother have any miscarriages? [1] NO [2] YES
IF YES, how many ________ and the sex (if known): ____ MALE ___ FEMALE
(indicate number)
Sibling Information
RELATION TO YOU
SEX
AGE
If not FULL siblings indicate relatedness: FULL, STEP, HALF,
ADOPTIVE
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(PROJECT USE ONLY – ID # _________________)
3. MEDICAL HISTORY
Were you ever diagnosed with ADHD or did you ever take a stimulant medication, such
as Ritalin? (please circle) [1] NO [2] YES
Are you currently taking medicine prescribed for ADHD? (please circle) [1] NO [2] YES
Have you ever had any kind of head injury? (please circle) [1] NO
[2] YES
IF YES, what happened ______________________________________________
IF YES, was there a loss of consciousness? (please circle) [1] NO [2] YES
IF YES, for how long (in hours)? ____________
Have you ever had a seizure? (please circle) [1] NO
IF YES, specify type:
[1] FEBRILE, specify # of times ______

[2] YES

[2] PETIT MAL/ABSENCE, specify # of times _____
[3] GRAND MAL/TONIC-CLONIC, specify # of times _____
[4] OTHER, please specify type _________________ and # of times ______
IF YES, were you ever medicated for seizures? (please circle) [1] NO [2] YES
Specify when and type of medication:________________________________
Have you ever been diagnosed with a learning disorder? [1] NO [2] YES
IF YES, please specify what kind ______________________________________
Have you ever been diagnosed with any mental disorder? [1] NO [2] YES
IF YES, please specify what kind ______________________________________
Are you currently taking any form of medication (except as indicated above)?
[1] NO [2] YES IF YES, please specify what kind _______________________
4. DEVELOPMENTAL HISTORY
Has anyone ever told you that you:
Started talking late?
Crawled or walked late?
Were difficult to manage as a young child?
Were late in being toilet trained?
Had problems getting along with other children?
Were aggressive toward others?
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[1] NO
[1] NO
[1] NO
[1] NO
[1] NO
[1] NO

[2] YES
[2] YES
[2] YES
[2] YES
[2] YES
[2] YES

(PROJECT USE ONLY – ID # _________________)
5. ACADEMIC HISTORY
Current Year? ________________

Major? _____________________________

Current CGPA? ________________
Do you like school? [1] NO

[2] YES

Are you having any difficulty in school? [1] NO

[2] YES

IF YES, please describe
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
Do you receive any special services at school? [1] NO

[2] YES

If YES, please specify
__________________________________________________________________
__________________________________________________________________

THANK YOU FOR TAKING THE TIME TO COMPLETE THIS
QUESTIONNAIRE !!

91

APPENDIX B

Pubertal Development Scale (PDS) - Women
Retrospective Version
7/28/04 CS, JZ, KK
Women show a large range of ages during which pubertal growth and
development occur. We are interested in learning more about this range of individual
differences in pubertal development. We ask you to help us get this information by
answering some questions about what you remember about your own pubertal
development.
When you are answering these questions, it is important to remember that no one
will see your answers other than the researchers doing this study, and that your name will
not be listed with your responses (just your identification number will be). Therefore,
please be as honest as possible since your honest answers will help us learn about
variability in these measures.
For many questions, we will ask you to estimate the age at which an event
occurred. Many people find it useful to think about other events that were occurring
around the same time to help them remember their age. For example, you may remember
that an event occurred in the fourth grade, but not immediately recall the age. In these
cases, you may be able to estimate your age based on these other memories and the grade
you were in at the time. For additional assistance throughout this questionnaire, please
also use the “grade level: age” conversion chart provided below.
Grade Level: Age Conversion Chart
Grade 1: 6 years old
Grade 2: 7 years old
Grade 3: 8 years old
Grade 4: 9 years old
Grade 5: 10 years old
Grade 6: 11 years old
Grade 7: 12 years old
Grade 8: 13 years old
Grade 9: 14 years old
Grade 10: 15 years old
Grade 11: 16 years old
Grade 12: 17 years old
Please remember to read the directions and each question carefully.
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Section I: In the following section, please pick the answer that best fits your
developmental profile. Please choose only ONE answer for each question.
(1) In general, do you think your development was any earlier or later than most other
girls?
1.
much earlier
2.
somewhat earlier
3.
about the same
4.
somewhat later
5.
much later
6.
don’t know
(2) Do you think your first period was any earlier or later than most other girls?
1.
much earlier
2.
somewhat earlier
3.
about the same
4.
somewhat later
5.
much later
6.
don’t know
(3) Do you remember the approximate age or grade at which you first menstruated?
1.
yes
2.
no
If you answered “yes”:
(4) How old were you when you had your first period?
a) ______ years and ______ months old
b) don’t know
(5) What grade were you in when you had your first period?
a) ______ grade
b) don’t know
(6) Do you think your breasts developed any earlier or later than most other girls?
1.
much earlier
2.
somewhat earlier
3.
about the same
4.
somewhat later
5.
much later
6.
don’t know
(7) Do you remember the approximate age or grade in which you first noticed changes in
your breasts or breast development?
1.
yes
2.
no
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If you answered “yes”:
(8) How old were you when you first noticed breast development?
a) ______ years and ______ months old
b) don’t know
(9) What grade were you in when you first noticed breast development?
a) ______ grade
b) don’t know
(10) Do you remember the approximate age or grade in which you wore your first
training bra?
1.
yes
2.
no
If you answered “yes”:
(11) How old were you when you wore your first training bra?
a) ______ years and ______ months old
b) don’t know
(12) What grade were you in when you wore your first training bra?
a) ______ grade
b) don’t know
(13) Both girls and boys go through a growth spurt before puberty, during which time
they rapidly increase in height, outgrowing their shoes and clothes. Would you say
that your growth in height was any earlier or later than other girls?
1.
much earlier
2.
somewhat earlier
3.
about the same
4.
somewhat later
5.
much later
6.
don’t know
(14) Do you remember the approximate age or grade at which you went through a
growth spurt?
1.
yes
2.
no
If you answered “yes”:
(15) How old were you when you went through a growth spurt?
a) ______ years and ______ months old
b) don’t know
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(16) What grade were you in when you went through a growth spurt?
a) ______ grade
b) don’t know
(17) Body hair (“body hair” meaning underarm and pubic hair) also begins to grow
during puberty. Would you say that your growth of body hair was any earlier or
later than other girls?
1.
much earlier
2.
somewhat earlier
3.
about the same
4.
somewhat later
5.
much later
6.
don’t know
(18) Do you remember the approximate age or grade at which you began to grow body
hair?
1.
yes
2.
no
If you answered “yes”:
(19) How old were you when you began to grow body hair?
a) ______ years and ______ months old
b) don’t know
(20) What grade were you in when you began to grow body hair?
a) ______ grade
b) don’t know
(21) Hormonal changes during puberty can dramatically change the chemistry of the
facial skin, causing pimples and acne. Would you say your skin changed any
earlier or later than other girls?
1.
much earlier
2.
somewhat earlier
3.
about the same
4.
somewhat later
5.
much later
6.
don’t know
(22) Do you remember the approximate age and grade in which your skin started
changing?
1.
yes
2.
no
If you answered “yes”:
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(23) How old were you when your skin started to change?
a) ______ years and ______ months old
b) don’t know
(24) What grade were you in when your skin started to change?
a) ______ grade
b) don’t know
(25) Birth control pills and other types of hormonal contraceptives (e.g., Depo-Provera)
are prescribed by doctors prior to the age of 18 for a variety of reasons, including
but not limited to acne, irregular menstrual cycles, and as a form of pregnancy
prevention. Are you currently taking hormonal contraceptives?
1.
yes (specify brand, if known):
2.
no
(Did you take any of these types of hormonal contraceptives before the age of 18?
1.
yes
2.
no
3.
don’t know
If you answered “yes,” please answer the following questions:
Hormonal contraceptive(s) taken:
___ birth control pills (specify brand, if known):
___ birth control injections (e.g. Depo-Provera, specify type if known):
other (specify):
Age start: I was ______ years and ______ months old when I began taking hormonal
contraceptives.
Grade start: I was in the ____ grade when I began taking hormonal contraceptives.
Between the start age and the age of 18, did you take hormonal contraceptives?
3. continuously
4. stopped and started (had more than one period of use)
5. stopped after a single period of use
If you stopped after a single period of use, what age were you when you stopped
taking hormonal contraceptives?
Age: I was ______ years and ______ months old when I stopped taking hormonal
contraceptives.
Grade: I was in the ____ grade when I stopped taking hormonal contraceptives.
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APPENDIX C

BAARS-IV: Self Report - Current
Instructions
For the first 27 items, please circle the number next to each item below that best
describes your behavior DURING THE PAST 6 MONTHS. Then answer the remaining
three questions.

	
  
1. Fail to give close attention to details or make
careless mistakes in my work or other activities
2. Difficulty sustaining my attention in tasks or fun
activities
3. Don’t listen when spoken to directly
4. Don’t follow through on instructions and fail to
finish work or chores
5. Have difficulty organizing tasks and activities
6. Avoid, dislike, or am reluctant to engage in tasks
that require sustained mental effort
7. Lose things necessary for tasks or activities
8. Easily distracted by extraneous stimuli or
irrelevant thoughts
9. Forgetful in daily activities
10. Fidget with hands or feet or squirm in seat
11. Leave my seat in classrooms or in other
situations in which remaining seated is expected
12. Shift around excessively or feel restless or
hemmed in
13. Have difficulty engaging in leisure activities
quietly (feel uncomfortable, or am loud or noisy)
14. I am “on the go” or act as if “driven by a motor”
(or I feel like I have to be busy or always doing
something)
15. Talk excessively (in social situations)
16. Blurt out answers before questions have been
completed, complete others’ sentences, or jump
the gun
17. Have difficulty awaiting my turn
18. Interrupt or intrude on others (butt into
conversations or activities without permission or
take over what others are doing)
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3

4
4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3
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1
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19. Prone to daydreaming when I should be
concentrating on something or working
20. Have trouble staying alert or awake in boring
situations
21. Easily confused
22. Easily bored
23. Spacey or “in a fog”
24. Lethargic, more tired than others
25. Underactive or have less energy than others
26. Slow moving
27. I don’t seem to process information as quickly
or as accurately as others

Never
or
rarely

Sometimes

Often

Very
often

1

2

3

4

1

2

3

4

1
1
1
1
1
1

2
2
2
2
2
2

3
3
3
3
3
3

4
4
4
4
4
4

1

2

3

4

28. Did you experience any of these 27 symptoms at least “Often” or more frequently
(Did you circle a 3 or a 4 above)?
No
Yes (Circle one)
29. If so, how old were you when those symptoms began? (Fill in the blank)
I was ______________ years old.
30. If so, in which of these settings did those symptoms impair your functioning? Place a
check mark (√) next to all the areas that apply to you.
______ School
______ Home
______ Work
______ Social Relationships

98

APPENDIX D

BDEFS-LS: Self Report
Instructions
How often do you experience each of these problems? Please circle the number next to
each item that best describes your behavior DURING THE PAST 6 MONTHS.

	
  
1.

Procrastinate or put off doing things until the
last minute
2. Poor sense of time
3. Waste or mismanage my time
4. Not prepared on time for work or assigned tasks
5. Fail to meet deadlines for assignments
6. Have trouble planning ahead or preparing for
upcoming events
7. Forget to do things I am supposed to do
8. Can’t seem to accomplish the goals I set for
myself
9. Late for work or scheduled appointments
10. Can’t seem to hold in mind things I need to
remember to do
11. Can’t seem to get things done unless there is an
immediate deadline
12. Have difficulty judging how much time it will
take to do something or get somewhere
13. Have trouble motivating myself to start work
14. Have difficulty motivating myself to stick with
my work and get it done
15. Not motivated to prepare in advance for things I
know I am supposed to do
16. Have trouble completing one activity before
starting into a new one
17. Have trouble doing what I tell myself to do
18. Difficulties following through on promises or
commitments I may make to others
19. Lack self-discipline
20. Have difficulty arranging or doing my work by
its priority or importance; can’t “prioritize” well
21. Find it hard to get started or get going on things
I need to get done
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2

3

4

1

2

3
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22. I do not seem to anticipate the future as much or
as well as others
23. Can’t seem to remember what I previously heard
or read about
24. I have trouble organizing my thoughts
25. When I am shown something complicated to do,
I cannot keep the information in mind so as to
imitate or do it correctly
26. I have trouble considering various options for
doing things and weighing their consequences
27. Have difficulties saying what I want to say
28. Unable to come up with or invent as many
solutions to problems as others seem to do
29. Find myself at a loss for words when I want to
explain something to others
30. Have trouble putting my thoughts down in
writing as well or as quickly as others
31. Feel I am not as creative or inventive as others
of my level of intelligence
32. In trying to accomplish goals or assignments, I
find I am not able to think of as many ways of
doing things as others
33. Have trouble learning new or complex activities
as well as others
34. Have difficulty explaining things in their proper
order or sequence
35. Can’t seem to get to the point of my
explanations as well as others
36. Have trouble doing things in their proper order
or sequence
37. Unable to “think on my feet” or respond as
effectively as others to unexpected events
38. I am slower than others at solving problems I
encounter in my daily life
39. Easily distracted by irrelevant events or thoughts
when I must concentrate on something
40. Not able to comprehend what I read as well as I
should be able to do; have to reread material to
get its meaning
41. Cannot focus my attention on tasks or work as
well as others
42. Easily confused
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43. Can’t seem to sustain my concentration on
reading, paperwork, lectures, or work
44. Find it hard to focus on what is important from
what
is not important when I do things	
  
44. I don’t seem to process information as quickly or
as accurately as others
45. Find it difficult to tolerate waiting; impatient
46. Make decisions impulsively
47. Unable to inhibit my reactions or responses to
events or others
48. Have difficulty stopping my activities or
behaviour when I should do so
49. Have difficulty changing my behaviour when I
am given feedback about my mistakes
50. Make impulsive comments to others
51. Likely to do things without considering the
consequences for doing them
52. Change my plans at the last minute on a whim or
last minute impulse
53. Fail to consider past relevant events or past
personal experiences before responding to
situations (I act without thinking)
54. Not aware of things I say or do
55. Have difficulty being objective about things that
affect me
56. Find it hard to take other people’s perspectives
about a problem or situation
57. Don’t think about or talk things over with myself
before doing something
58. Trouble following the rules in a situation
59. More likely to drive a motor vehicle much faster
than others (Excessive speeding)
60. Have a low tolerance for frustrating situations
61. Cannot inhibit my emotions as well as others
62. I don’t look ahead and think about what the
future outcomes will be before I do something (I
don’t use my foresight)
63. I engage in risk taking activities more than others
are likely to do
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64. Likely to take short cuts in my work and not do
all I am supposed to do
65. Likely to skip out on work early if my work is
boring to do
66. Do not put as much effort into my work as I
should or than others are able to do
67. Others tell me I am lazy or unmotivated
68. Have to depend on others to help me get my work
done
69. Things must have an immediate payoff for me or
I do not seem to get them done
70. Have difficulty resisting the urge to do
something fun or more interesting when I am
supposed to be working
71. Inconsistent in the quality or quantity of my
work performance
72. Unable to work as well as others without
supervision or frequent instruction
73. I do not have the willpower or determination
that others seem to have
74. I am not able to work toward longer term or
delayed rewards as well as others
75. I cannot resist doing things that produce
immediate rewards even if they are not good for
me in the long run
76. Quick to become angry or become upset
77. Overreact emotionally
78. Easily excitable
79. Unable to inhibit showing strong negative or
positive emotions
80. Have trouble calming myself down when once I
am emotionally upset
81. Cannot seem to regain emotional control and
become more reasonable once I am emotional
82. Cannot seem to distract myself away from
whatever is upsetting me emotionally to help me
calm me down. I can’t refocus my mind to a
more positive framework.
83. Unable to manage my emotions in order to
accomplish my goals successfully or get along
well with others
84. I remain emotional or upset longer than others
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85. I find it difficult to walk away from emotionally
upsetting encounters with others or leave
situations in which I have become very
emotional
86. I cannot rechannel or redirect my emotions into
more positive ways or outlets when I get upset
87. I am not able to evaluate an emotionally
upsetting event more objectively
88. I cannot redefine negative events into more
positive viewpoints when I feel strong emotions
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APPENDIX E

DERS
Please indicate how often the following statements apply to you by writing the
appropriate number from the scale below on the line beside each item:
________________________________________________________________________
1-------------------2------------------------3------------------------4-----------------------5
almost never
sometimes
about half the time
most of the time almost always
(0-10%)
(11-35%)
(36-65%)
(66-90%)
(91-100%)
______ 1) I am clear about my feelings.
______ 2) I pay attention to how I feel.
______ 3) I experience my emotions as overwhelming and out of control.
______ 4) I have no idea how I am feeling.
______ 5) I have difficulty making sense out of my feelings.
______ 6) I am attentive to my feelings.
______ 7) I know exactly how I am feeling.
______ 8) I care about what I am feeling.
______ 9) I am confused about how I feel.
______ 10) When I’m upset, I acknowledge my emotions.
______ 11) When I’m upset, I become angry with myself for feeling that way.
______ 12) When I’m upset, I become embarrassed for feeling that way.
______ 13) When I’m upset, I have difficulty getting work done.
______ 14) When I’m upset, I become out of control.
______ 15) When I’m upset, I believe that I will remain that way for a long time.
______ 16) When I’m upset, I believe that I’ll end up feeling very depressed.
______ 17) When I’m upset, I believe that my feelings are valid and important.
______ 18) When I’m upset, I have difficulty focusing on other things.
______ 19) When I’m upset, I feel out of control.
______ 20) When I’m upset, I can still get things done.
______ 21) When I’m upset, I feel ashamed with myself for feeling that way.
______ 22) When I’m upset, I know that I can find a way to eventually feel better.
______ 23) When I’m upset, I feel like I am weak.
______ 24) When I’m upset, I feel like I can remain in control of my behaviors.
______ 25) When I’m upset, I feel guilty for feeling that way.
______ 26) When I’m upset, I have difficulty concentrating.
______ 27) When I’m upset, I have difficulty controlling my behaviors.
______ 28) When I’m upset, I believe that there is nothing I can do to make myself feel
better.
______ 29) When I’m upset, I become irritated with myself for feeling that way.
______ 30) When I’m upset, I start to feel very bad about myself.
______ 31) When I’m upset, I believe that wallowing in it is all I can do.
______ 32) When I’m upset, I lose control over my behaviors.
______ 33) When I’m upset, I have difficulty thinking about anything else.
______ 34) When I’m upset, I take time to figure out what I’m really feeling.
______ 35) When I’m upset, it takes me a long time to feel better.
______ 36) When I’m upset, my emotions feel overwhelming.
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APPENDIX F

BFIS-LF: Self Report
Instructions
How much difficulty do you have functioning effectively in each of these major life
activities? That is, to what degree do you see yourself as being impaired in each of these
life domains? Please circle the number next to each item that best describes your
difficulties in functioning DURING THE PAST 6 MONTHS. If that situation does not
apply to you (for instance, you don’t drive a car, don’t have children, don’t live with
anyone, etc.), please circle the 99 in the last column (under “Does not apply”)
Major Life Activities
1. In your home life with
your immediate
family
2. In getting chores
completed at home
and managing your
household
3. In your work or
occupation
4. In your social
interactions with
strangers and
acquaintances
5. In your relationships
with friends
6. In your activities in
the community
(church, clubs, social
groups,
organizations)
7. In any educational
activities (college,
night classes,
technical training,
occupational
training).
8. In your marital, coliving, or dating
relationships
9. In your management
of your money, your
bills, and your debts

Not
at all
0

Somewhat
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Moderate

Severe
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105

99

Major Life Activities
10. In driving a motor
vehicle and in your
history of citations
and accidents
11. In your sexual
activities and sex
relations with others
12. In your organization
and management of
your daily
responsibilities
13. In caring for yourself
daily (dressing,
bathing and hygiene,
eating, sleeping, etc.)
14. In maintaining your
health (exercise,
nutrition, preventive
medical and dental
care, etc.)
15. In taking care of and
raising your children

Not
at all

Somewhat

Mild

Moderate

Severe

Does
not
apply
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APPENDIX G

RISK-TAKING BEHAVIOUR QUESTIONNAIRE
Please indicate which behaviours you have engaged in over the LAST SIX MONTHS.
N/Y

HOW OFTEN?

DRIVING
Have you exceeded the speed limit?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you NOT worn a seatbelt in a moving car?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you driven without a license?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you been a passenger with a drunk driver?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you ever driven after drinking?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you smoked marijuana?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you used cocaine or crack?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you used heroine or another illegal opiate?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you used inhalants (e.g. “huffing”)

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

DRUGS/ALCOHOL/CIGARETTES

Have you used prescription drugs not prescribed by a doctor or that were not prescribed for you?
[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you consumed alcohol?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you smoked cigarettes?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you used any other illegal drug?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

LAW BREAKING
Have you broken any laws with non-violent behaviour (e.g., shoplifting)?
[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you broken any laws with violent behaviour (e.g., assault with or without a weapon)?
[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you ever broken probation or other legal agreement?
[1] NO

Have you had an interaction with the police that resulted in arrest or detainment?
[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you had sexual intercourse?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you had oral sex?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Have you had anal sex?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

FAMILY RULES BROKEN
Have you broken any rules set by your family (e.g.., curfew)?
SEXUAL BEHAVIOUR

Have you NOT used a condom or any other barrier method when engaged in sexual activity with a partner?
Have you been paid for sexual activity?

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

[1] NO

[2] YES

Never

Once

2-5 times

6-10 times

11 or more times

Never

Once

2-5 times

6-10 times

11 or more times

Have you had sexual activity with more than one person in a 24-hour period?
[1] NO
Age at first sexual intercourse?

[2] YES

___________ years

Total life-time number of sexual partners?

____________
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